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EXECUTIVE SUMMARY 
The development of the Operational Plan for Comprehensive Care, Management and 
Treatment (CCMT) in 2003, hereafter referred to as the CCMT Plan, coincided with the 
formulation of the “3 By 5” initiative spearheaded the World Health Organisation and 
the Joint United Nations Programme on HIV/AIDS (UNAIDS). The CCMT Plan 
affirmed the commitment of the South African government to do something to slow the 
increasing number of HIV (Human Immuno deficiency Virus) infections and AIDS 
deaths across South Africa. The Plan set the target of providing universal access to Anti 
Retroviral Therapy (ART) to one million people through the public sector by the end of 
2007. The programme was implemented in April 2004, with many sites opening later that 
year after extensive preparation and planning. As the programme began to expand across 
South Africa, it became clear that the public health system required considerable 
strengthening if it was to come close to reaching one million people by the end of 2007.  
 
By March 2007, 264 423 people were reportedly receiving ART in 313 accredited sites 
across South Africa, most of them in the routine public sector institutional environment 
(National Treasury, 2007a). The Gauteng Department of Health has itself enrolled more 
than 95 000 people in the ART Programme and has one of the largest and fastest 
growing programmes in South Africa (Schneider et al, 2008). 
 
This study aimed to assess the organisational capacity within two CCMT sites. Site A is a 
hospital with a capacity of 784 beds and Site B is a Community Health Centre (CHC) 
providing out-patient services. The sites that form part of this study began providing 
treatment in July 2004 and October 2004 respectively. Both programmes were nurse-
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centred and CCMT Managers had prior experience in the provision of ART prior to the 
national roll-out in 2004. 
 
Site A provided ART, Voluntary Counselling and Testing (VCT), Prevention of Mother-
to-Child Transmission (PMTCT) services and initiated patients on TB treatment. Site B 
provided the same services in addition to a comprehensive TB service and a well-
established Wellness Programme that was run within the facility.  The study utilised data 
from semi-structured interviews with facility, CCMT site and Programme Managers and 
staff working in TB, PMTCT and VCT services. In addition, routine data was reviewed, 
facility mapping conducted, 35 self-administered questionnaires (SAQ) on motivation 
completed, and the clinical outcomes of 355 patients who participated in exit interviews 
were reviewed. These interviews were conducted for another MPH research study as part 
of the overall CIDA Rapid Response Grant. 
 
The study utilised Wagner’s Chronic Care Model to assess various aspects of chronic 
disease care. The Model consists of four main components. These are prepared proactive 
practice teams, delivery systems design, decision support and clinical information 
systems. Aspects that were studied included staffing levels, motivation, workload, 
infrastructure, space, support systems and monitoring and evaluation processes. 
 
 The study generated important findings that can be used to inform future decision-
making in relation to facility accreditation and resource allocation within the CCMT 
Programme as a whole. All staff that completed a SAQ were confident about their ability 
to do their job and the majority were proud to be working in each site. Worryingly, the 
majority felt emotionally drained at the end of each day and felt there were not sufficient 
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staff to do the work in the CCMT service. This was confirmed by the gaps in required 
staffing as outlined in the accreditation criteria.  
 
There was evidence of strong inter-personal relationships between staff and patients in 
Site A and services were well-integrated. Where gaps existed, these pertained to the 
division of responsibility in the management of TB and the lack of a Wellness service due 
to space constraints. Services were also well-integrated and this perception was shared by 
staff working in both sites.  
 
Overall, Site B performed better in the management and use of data but appeared weaker 
in levels of motivation and personal relationships among staff. Both sites felt there was a 
need for more support from the Region and a strong need for emotional support for 
staff working in the CCMT service. Similarly, both sites experienced space constraints 
and were struggling to meet the needs of the growing numbers of patients attending the 
ART clinics. In particular, there was a growing gap in the number of patients prepared 
and initiated on treatment each month in Site A. The delay in starting patients on ART 
was exacerbated by the lack of staff within the Unit. Both sites experienced few logistical 
problems pertaining to drug supply and the turn-around time for laboratory test results. 
Where some minor problems were encountered, each site was able to put in place 
contingency measures to manage these problems. Adherence levels in both sites were 
high. Adherence levels, at 89.5% in Site A and 85.4% in Site B. It was difficult to assess 
whether these levels are likely to be maintained as the CCMT Programme continues to 
expand in both sites.  
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In light of the findings described above, there are important recommendations to be 
noted: 
• More structured emotional support should be provided to staff on a regular basis 
with specific resources being allocated within each facility budget; 
• Staff who are trained in CCMT content and procedures should not be moved to an 
alternate unit within facilities in order that such knowledge is not lost and is used to 
improve the quality of care; 
• The Staffing Plan outlined in the Operational Plan (2003) needs to be reviewed in 
line with realistic staffing allocations in light of the human resource crisis that exists 
within the health system; 
• Where possible, tasks should be re-allocated to lower level staff to decrease the 
pressure on higher-level staff and thus contribute to improving the skills base within 
the public health system; 
• Lay-counsellors and auxiliary staff need to receive training that is accredited and 
standardised and is recognised as a formal qualification thereby ensuring a basic level 
of assumed knowledge and understanding;  
• The allocation of funding to Non-Governmental Organisations (NGOs) to manage 
lay counsellors needs to be reconsidered in light of funding delays and problems with 
accountability at facility level; 
• The decentralisation of treatment access through the accreditation of Primary Health 
Care clinics and sites at community-level needs to be prioritised in order to reduce 
the pressure on existing services and the risk of a decline in the quality of care; 
• TB/HIV co-infection needs to be carefully managed and monitored so as to prevent 
the fall-out of patients from the health system. This is particularly important in light 
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of the division of responsibility between provincial and local government health 
facilities; and  
• Careful attention needs to be dedicated to the formulation of indicators that are used 
for Monitoring & Evaluation in order to ensure that data collected provides a valid 
and accurate picture of site-level functioning and long-term patient outcomes. 
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CHAPTER 1 – INTRODUCTION 
 
1.1 Background and rationale 
South Africa can lay claim to implementing the largest public sector ART Programme in the 
world. This programme was initiated in 2004 after considerable pressure on government 
from civil society to act against the escalating number of HIV infections and AIDS deaths in 
South Africa. It also emerged at a time when there was growing recognition internationally 
of the need to develop an emergency response to the escalating HIV pandemic. Many of the 
poorest countries in the world were hardest hit. 
 
This global response took the form of the ‘3 by 5’ initiative led by the World Health 
Organisation and UNAIDS. At the start of the initiative, it was believed that six million 
people needed ART in such countries, but only 8% were receiving it. The initiative aimed to 
extend ART to three million people in low and middle-income countries by 2005. This was 
estimated to be 50% of the people who needed it. The initiative achieved some momentum 
and saw an increase in the number of people accessing ART in the target countries, but fell 
far short of achieving its goal. By the end of 2005, 810 000 people were receiving treatment 
in sub-Saharan Africa. This was an eight fold increase from 100 000 in 2003. South Africa 
accounted for approximately 25% of these, though it had not achieved its own targets 
(Nemes et al, 2006). This initiative, coupled with extensive work and funding provided by 
international donors and UNAIDS has culminated in improvements in some countries, with 
less people dying and infection rates slowing.  
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By 2005, the South African National HIV Prevalence Survey found that HIV prevalence 
among the general population was 16.2% (South African Department of Health, 2007). The 
National HIV and Syphilis Prevalence Survey conducted in 2006 found that HIV prevalence 
among pregnant women was 30.8%. This is a steady decline from 33.1% prevalence among 
pregnant women in 2004. Higher prevalence is recorded in the Kwa-Zulu Natal, Eastern 
Cape and Mpumalanga provinces (Dorrington et al, 2006). The roll-out of ART in the public 
sector in Gauteng has far out-paced the implementation of the CCMT Programme in the 
other three provinces. By October 2006, 53 285 adults were receiving ART as part of the 
public sector roll-out in Gauteng (South African Department of Health, 2006). While the 
number of new infections had peaked in Gauteng in 2005 and was slowing, prevalence 
among the general population remained high. By mid 2006, prevalence in Gauteng was 
estimated to be 14.5%, marginally lower than the national prevalence rate (Dorrington et al, 
2006). 
 
The Western Cape began providing ART in collaboration with Médecins sans Frontières 
(MSF) in 2001. Though the Western Cape had the lowest prevalence rate among pregnant 
women (8.6%) in the country, it was also experiencing large levels of in-migration from rural 
areas in pursuit of economic opportunity. At the time of initiating treatment programmes in 
Khayelitsha and Gugulethu, prevalence rates in these areas were not dissimilar to the 
national average (South African Department of Health, 2007). Gauteng began providing 
ART in 2004. It is one of the smallest provinces in South Africa, but has the greatest number 
of people. By 2007, Gauteng’s population was estimated to be 10 451 713 people (Statistics 
South Africa, 2007). It is the centre of economic activity and acts as a magnet for people 
within South Africa and across the continent. Prospects of employment fuel the movement 
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of people from rural areas. This has created the conditions for one of the most serious HIV 
scenarios in South Africa. 
 
The Department of Health’s CCMT Plan was released in 2003 and provided the foundation 
for the roll-out of ART in the public sector in April 2004. The CCMT Plan committed the 
South African government to put in place an integrated strategy for the management of 
HIV/AIDS which included the provision of Nevirapine for pregnant women and free 
universal access to Anti Retroviral Therapy to patients with a CD4 count below 200. The 
CCMT Plan was formulated with guiding principles that need to be considered when 
assessing the functioning of the CCMT Programme. These principles include equitable 
implementation and quality of care across provinces, ensuring the sustainability of all HIV 
related interventions, integration of health services and the pursuit of the World Health 
Organisation’s target of providing ART to three million people in developing countries by 
2005.  
 
An important underlying objective of the CCMT Plan was to strengthen the health system in 
order that it can achieve the goal of reaching and initiating one million patients on ART by 
the end of 2007.  The CCMT Plan was followed with the design of a Monitoring and 
Evaluation Framework to assess programme performance and identify system weaknesses 
(Department of Health, 2004a). This framework sets out very specific indicators and 
objectives and the lead agency responsible for each intervention. Many such objectives 
require the involvement and meaningful participation of many stakeholders and government 
institutions. This confirms the need for collaboration and cooperation. The framework 
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outlines specific indicators for prevention, care and treatment for vulnerable high-risk 
populations (South African Department of Health, 2007).   
 
By December 2007, 371 204 patients (adults and children) were on ART in the public sector 
across South Africa (South African Government, 2007). While South Africa has made great 
strides, it had not succeeded in reaching one million patients by the end of 2007. 
Implementation of the CCMT Plan varies across provinces and many sites are still awaiting 
accreditation. Many existing sites have reached the point of saturation and patients are being 
put on a waiting list. In others, the lack of skills and resources hampers the delivery of 
integrated services to patients. Without considerable increases in capacity and infrastructure, 
the gap between need and provision of ART will widen.  
 
It is anticipated that as the programme becomes more stable, the number of patients initiated 
on ART will increase more rapidly. The health system is already generally overburdened and 
is struggling to meet the needs of all patients. Without considerable strengthening and 
investment, there is a risk that the health gains achieved to date by the introduction of ART 
will be lost. 
 
Capacity issues include the fragmentation of health systems and a lack of integration between 
primary and secondary level care. The lack of collaboration and co-operation between 
services can significantly undermine continuity of care for patients who enter at primary care 
level and are referred into an already overburdened system that is struggling to monitor 
patients and maintain 95% adherence to ART, the primary criteria for achieving virological 
suppression. Literature demonstrates that levels of adherence may decline over time and are 
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influenced by the length of time a patient has been taking treatment. One study reports a 
decline in adherence after two years on ART (Rosen et al, 2007). The ART Programme 
provided in the public sector is in its fourth year of implementation. This highlights the need 
to monitor levels of adherence closely and to correctly identify and address barriers to 
maintaining patients on treatment.  
 
This research report will investigate the organisational capacity within two second generation 
CCMT sites in Gauteng. It will look at the level of integration between services, primary and 
secondary level health care sites and the resources available to support the initiation and 
retention of patients on treatment to realise effective clinical outcomes. A well-functioning 
CCMT Programme has the potential to realise considerable development gains for 
individuals, families and the economy. For this reason, the long-term success of the ART 
Programme in South Africa is crucial.  
 
1.2 Literature Review 
 
1.2.1 Chronic Care Model 
Chronic diseases are fast becoming one of the greatest burdens on health systems in the 
world today and require careful management to realise successful patient outcomes. Until 
recently, diabetes, hypertension and asthma were the main focus of chronic care. As the 
number of people living with HIV continues to increase, HIV is coming to be regarded as an 
urgent health emergency. In addition to this, it is also a chronic condition with the worst 
possible consequences if not managed effectively. To date, many health systems are based 
upon an acute model of care that is episodic in nature and does not consider the long-term 
  6 
needs of patients. This model misses out on an opportunity to leverage community resources 
to care for patients in a system that is already stretched. An acute model of care is resource-
intensive and will not be able to manage the increasing demand for health services into the 
future (World Health Organisation, 2002). In order to be able to meet the demands for 
chronic care, it became necessary to consider and develop an alternative model of care.  
 
One of the crucial components of effective chronic care is a well-functioning health system 
that ensures continuity, comprehensiveness and co-operation between service providers and 
patients. These three components provide the cornerstone of high quality care.  (Rothman & 
Wagner, 2003). Wagner’s Chronic Care Model (CCM) as cited in Epping-Jordan and Wagner 
(2004) proposes a model of care that maximises resources and integrates services through 
strengthening health systems. The Model has four components. These are Self Management 
Support, Delivery Systems Design, Decision Support and Clinical Information Systems 
(Lewis et al, 2004).  
 
• Self-Management Support refers to patient education and the empowerment of 
patients to take decisions regarding their health and health care through goal setting, 
problem solving and follow-up; 
 
• Delivery Systems Design refers to the availability of resources such as drugs, 
laboratory equipment, physical space, institutional environment, role definition and 
task allocation within health care teams and the degree of integration within the 
health system; 
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• Decision Support refers to the availability and application of appropriate protocols, 
policies and guidelines in treatment; 
 
• Clinical Information Systems refers to the collection and availability of relevant data 
and the use of such data to inform long-term care, allow for early intervention where 
health status changes, obtain and provide feedback and manage the long-term 
prognosis of patients taking chronic medication. 
 
In addition to these four aspects, the interaction and relationships between health care 
providers and patients can have considerable impact upon patient outcomes. 
 
 
Figure 1: Wagner’s Chronic Care Model (Wagner et al, 2001) 
 
This model was initially developed in the United States of America and was conceived with 
the structure of the US health system in mind. The health care needs and environment differ 
considerably in the developing world. For this reason, The World Health Organisation 
(WHO) recognised the need to develop a Chronic Care Model that can provide the 
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framework for the delivery of chronic care in countries with resource limitations.  
 
This culminated in the Innovative Care for Chronic Conditions (ICCC) Framework. This 
framework looks more broadly at multiple factors influencing the quality of care provided to 
patients and how this impacts upon clinical outcomes (WHO, 2002). It locates each of these 
factors at the micro, meso and macro level. The ICCC Framework is considerably broader in 
focus than Wagner’s CCM. It places considerable emphasis upon comprehensive changes in 
the design of health systems, encompassing both internal and external factors (Epping-
Jordan et al, 2004).  
 
Figure 2: The Innovative Care for Chronic Conditions Framework (WHO, 2002). 
 
At the micro level, the ICCC Framework focuses on the patient and family. Acute models of 
care have been focused on the micro level. This has historically been the predominant 
emphasis in health systems. The meso level focuses on the healthcare organisation and 
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community and the macro level focuses on broader policy objectives. The Chronic Care 
Model proposed by Epping-Jordan and Wagner focuses on the meso level. The major 
contribution of the ICCC Framework is the emphasis upon macro level components. 
Examples of macro-level components are policy and higher-level decision making. The 
ICCC Framework emphasized the need for multi-pronged health interventions to achieve 
effective clinical outcomes over the longer-term. The CCMT Plan has gone some way to 
achieving this by regarding the provision of ART as only one element of a comprehensive 
AIDS strategy that includes prevention, wellness, nutrition, the management of Sexually 
Transmitted Infections (STIs) and Tuberculosis (TB).  
 
Figure 3: Effect of 3 scenarios of intervention in sub-Saharan Africa from 2003-2020 (Piot, 
2006).  
 
The ICCC Framework calls for integration between communities, patients, health care 
organisations and policies (WHO, 2002). The focus on integration is a considerable 
departure from vertical programmes that are resource-intensive, operate in isolation and do 
not facilitate communication and collaboration.  
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1.2.2 Measurement and markers for adherence 
Adherence is described as “an engagement and accurate participation of an informed patient 
in a plan of care” (Rabkin et al in Healthlink Worldwide, 2006). This definition confirms that 
long-term adherence requires patient involvement, a planned approach and needs to be 
carefully monitored. The extent to which these elements are present is influenced by the 
environment in which treatment takes place and the resources available to support effective 
clinical outcomes. In patients taking ART, virological suppression is regarded as an effective 
clinical outcome. 
 
Adherence to ART can be measured through self-reporting, pill counts and clinical 
outcomes. Research into adherence tends to use clinical outcomes of CD4 count and viral 
load results as the most reliable assessment of adherence (Orrell et al, 2003 and Coetzee et al, 
2004). A large body of literature on adherence defines a patient who has taken 95% of their 
tablets in a specific time period as adherent. This is known as dose adherence. Dose 
adherence is the measure that will be used for this study. The second measure is schedule 
adherence. Schedule adherence includes whether the patient also took the medication at the 
correct time (Murphy et al, 2004). This is harder to measure accurately but is also important 
as it has been found that taking ART at a different time to that specified may reduce the rate 
of virological suppression. Literature has shown that adherence measures are often 
inconsistent. The most common measures used are those of CD4 counts and viral load 
suppression. 
 
Reported retention rates in sub-Saharan Africa over a 24 month period vary from 39.2% in 
Uganda to 90.3% in South Africa (Rosen et al, 2007).  This makes South Africa the country 
  11 
with the highest number of patients retained on treatment across the continent. This is 
particularly noteworthy when considering that treatment completion rates on short-term 
treatment for TB are lower. In Gauteng, 71.7% of patients completed TB treatment and 
6.9% of patients defaulted on TB treatment in 2005 (Day and Gray, 2007). 
 
 
1.2.3 Experience of South Africa 
The roll-out of ART in South Africa has taken place in two phases. The first phase was the 
introduction and management of NGO-led sites by organisations such as MSF and Hanan 
Crusaid. These sites are referred to as first generation sites and have provided many valuable 
lessons in the implementation of the CCMT Plan. First generation sites pioneered the 
provision of ART in South Africa and were donor-funded. At the time of initiating the 
research, these sites were relatively stable and had overcome many of the problems 
experienced by the ‘second generation’ sites that were operating in the public sector 
environment and had rolled out treatment once the CCMT Plan was approved. Some of the 
‘first generation’ sites have since become independent of their initial donor agencies and 
have been handed over to the Department of Health in respective provinces. This has 
happened in the Western Cape and Eastern Cape.  
 
Available literature which reflects on the evolution of the public sector treatment programme 
in South Africa is informed by treatment programmes in the ‘first generation sites’ of 
Gugulethu, Khayelitsha and Lusikisiki. Gugulethu and Khayelitsha are two major urban 
townships in the Western Cape that have grown rapidly as people move from rural areas to 
urban areas in pursuit of economic opportunity. In contrast to this, Lusikisiki is a densely 
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populated rural sub-district in the Eastern Cape province. This is one of the poorest 
provinces in South Africa (Statistics South Africa, 2003). The programme in Gugulethu was 
initiated by a British NGO, Hanan Crusaid, in 2002. The programmes in Khayelitsha and 
Lusikisiki were initiated by MSF. MSF, in collaboration with the Western Cape Department 
of Health began providing ART in three Khayelitsha Community Health Centres in 2001 
and began providing ART in Lusikisiki in 2003. Each of these innovator programmes 
contribute important lessons for treatment programmes in South Africa.  
 
The second phase of the ART roll-out in South Africa began once the CCMT Plan had been 
approved and public sector sites were identified for accreditation. Programmes initiated 
within ‘first generation sites have expanded rapidly in resource-constrained settings and have 
been able to maintain high numbers of patients on treatment. Research undertaken in 
Gugulethu (Bekker et al. 2006) reports that after 12 months, 82% of patients receiving 
treatment at a clinic were retained in the programme and all had achieved viral load 
suppression below 400 copies per ml. Similarly, 81% of patients receiving treatment at a 
clinic in Lusikisiki were still on treatment after 12 months and 90% had achieved virological 
suppression. (Ford et al, 2006).  
 
Both these programmes confirm that it is possible to achieve effective clinical outcomes in 
low-income countries. It is worthwhile noting that the number of patients in Khayelitsha 
with undetectable viral loads decreased to 84.2% after 12 months, 75% after 18 months and 
69.7% after 24 months respectively. Patient retention is recorded as 83.5% over the study 
period. This demonstrates the difficulty of retaining patients on treatment over time and 
highlights that programme saturation can negatively impact the quality of care provided to 
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patients. As programmes have expanded, the gap between need and provision has narrowed. 
However, without sufficient attention to quality of care, there is a risk that the gap between 
need and provision widens again leading to a reversal in the health gains realised to date. 
 
This is especially important to consider as South Africa enters the fourth year of its national 
treatment programme and faces the risk of compromising programme performance as the 
public sector programme expands and the number of patients enrolled and initiated on ART 
continues to increase. 
 
The treatment programme initiated in Gugulethu had almost double the number of patients 
than the clinic in Khayelitsha but showed smaller declines in adherence levels over time. This 
programme was initiated in 2002 by the Western Cape Department of Health and had 
enrolled 1139 patients by October 2005. In the first year of study, 161 patients were initiated 
on ART. In the following two years, 280 and 698 patients were enrolled respectively.  
 
Despite the high numbers of patients, the programme in Gugulethu saw a smaller decline in 
the number of patients who did not have undetectable viral loads. This figure varied from 
100% in 2003, to 92% in 2004 and 98% in 2005, despite this programme serving almost 
double the number of patients than the three MSF-led clinics providing ART in Khayelitsha. 
The Gugulethu programme placed counsellors at the centre of patient support and saw a 
four-fold increase in the number of counsellors (6 to 28) from 2002 to 2005. Patient 
retention levels in Gugulethu were reported as 90.3%.  
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Both these programmes demonstrate that nurse-centred programmes in combination with 
thorough patient preparation can achieve effective clinical outcomes. Both studies also 
advocate provision of treatment in primary care settings and it appears that treatment in 
primary care settings with a smaller number of patients can achieve higher rates of viral load 
suppression and patient retention (Bekker et al, 2006). This is in contrast to treatment 
programmes with a greater number of patients on treatment which demonstrate a 
concurrent decrease in patient retention, virological suppression and an increase in HIV-
related mortality. This provides one of the strongest cases for locating treatment 
programmes at primary level. This experience is echoed by the effective outcomes achieved 
in a clinic in Lusikisiki (Ford et al, 2006).  
 
Research on high levels of loss to follow-up conducted in an urban public sector clinic in 
Johannesburg examined factors affecting retention on treatment among 15% (267 of 1631) 
of patients who were classified as lost to follow up after six weeks of discontinuing ART in 
the clinic. The study conducted retrospective analysis on such patients to establish reasons 
for loss to follow-up. High rates of mortality were noted in patients who had initiated ART 
in the last 30 days (83% of all deaths). Mortality was also higher among patients who were 
older at the time of clinic enrolment. Patients may also only seek care once they are very sick 
and their health may have deteriorated further in the time between presenting for care and 
initiating ART. This highlights the importance of ensuring that patients eligible for ART can 
access treatment as soon as possible.  
 
It is likely that such deaths could be avoided by earlier initiation of treatment and more 
efficient referrals to ART clinics. A high prevalence of prior or current TB infection was 
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noted in patients lost to follow up. This could be attributed to poor coordination of TB and 
HIV services and the difficulty of managing two chronic conditions simultaneously. In many 
instances, patients were receiving TB treatment at a different clinic. It is possible that either 
service was not aware of the patients overall health status and there was little communication 
between services. The integration of services will result in lower levels of morbidity and 
mortality for both conditions (Dalal et al, 2008). Factors identified in non-mortality loss to 
follow-up included relocation, transfers to another ART clinic and hospitalisation. Each of 
the identified factors can be associated with systems functioning and integration across 
services. 
 
1.2.4 The international experience 
Participation of patients in ART treatment programmes in developing countries is equivalent 
or better than adherence levels reported in the United States of America (USA). One study 
in the USA reports 74% adherence among patients who were followed up after eight months 
on ART (Paterson et al, 2000). The eight month follow-up period is a relatively short period 
of time. Higher levels of adherence were recorded in patients in South Africa who had been 
followed up after 12 months. It is possible that levels of adherence and retention may 
improve as the programme begins to develop optimal strategies for patient retention (Rosen 
et al, 2007). The lower levels of adherence in the USA demonstrate that the availability of 
sufficient resources, higher income and education are not reliable predictors of adherence. 
 
In Haiti, 87% of patients who were initiated on ART were still registered in the programme 
12 months later. This demonstrates that successful treatment outcomes are achievable in 
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settings with limited resources. Thus, resource constraints should not be used as a 
justification to delay the provision of ART in low-income countries (Severe et al, 2005).  
 
Literature examining clinical outcomes in low and high income countries recorded very 
similar gains in CD4 counts. Clinical outcomes of patients from eighteen programmes in 
low-income countries in Africa, Asia and South America and twelve programmes in high-
income countries in Western Europe, the USA and Canada were analysed and compared to 
determine factors affecting adherence outcomes.  
 
Patients in low-income countries tended to start treatment with a considerably lower CD4 
count (108 cells) whereas patients participating in treatment programmes in high-income 
countries had started treatment with a considerably higher CD4 count (234 cells). This has 
been attributed to the tendency among poorer patients to delay accessing health care due to 
the associated costs of accessing treatment. Clinical outcomes were close to equal in high 
and low-income countries. After six months, patients had achieved gains of 106 CD4 cells in 
low-income countries and 103 CD4 cells in high income countries.  
 
At the same time, 76% patients in low-income settings and 77% of patients in high-income 
countries respectively had viral loads of less than 500 copies per ml after six months. This 
demonstrates that conditions prior to initiating treatment may influence outcomes but that 
clinical outcomes between low and high income countries do not differ considerably. This is 
indicated in the higher levels of mortality in the first three months of treatment in low-
income countries. This has been attributed to complications associated with late stage AIDS 
infection (ART-LINC and ART-CC Collaboration, 2006). 
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1.2.5 Health systems capacity 
South Africa faces two major challenges as it continues to implement the CCMT Plan. These 
are the need to rapidly scale-up and expand the treatment programme and the need to 
sustain the delivery of high quality patient care in sites that have been in operation since 2004 
and are approaching saturation. The ability of the public health system to respond to and 
address these challenges is considerably influenced by the organisational capacity within 
CCMT sites. 
 
The roll-out of the ART Programme has taken various forms across provinces. In the Free 
State province, implementation has taken place in a decentralised manner and has a primary 
health care orientation. This has spread the patient load more evenly and among more 
personnel (Steyn et al, 2006). It has also brought treatment closer to communities and 
thereby reduced the costs of accessing treatment. In Gauteng, treatment programmes were 
initiated and are still only located in hospitals and Community Health Centres (CHCs). Many 
such sites are approaching saturation and are proposing that patients are down-referred. This 
has been used as an argument for managing increased patient loads in accredited sites across 
South Africa. It has received mixed responses from clinicians, NGOs working in the sector 
and government. Many clinicians and NGOs are in disagreement with this strategy as it 
hampers the integration of services and creates huge potential for patients to be lost in the 
system. This is exacerbated by the division of responsibility for primary health care clinics 
and hospitals between local and provincial government respectively. 
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 Literature proposes that ART services be located at PHC level because these sites are 
generally closer and more acceptable to the community, meaning that people seek treatment 
earlier and stay healthier for longer. The greater number of primary health care clinics also 
means that there are more sites providing ART in each district. This approach is valuable 
because it allows for the rapid expansion of programmes while maintaining optimal patient 
load.  
 
1.2.6 Human Resources for health 
The primary health care orientation of services means that clinical tasks are performed by 
professional nurses and that the allocation of traditional tasks and duties is reconsidered. The 
approach of task shifting is increasingly being perceived as a viable response to critical human 
resource constraints (WHO, 2007). Task shifting requires careful assessment of 
competencies but has proved very important to expanding treatment without compromising 
the quality of care and ensuring that available human resources are utilised to best effect. The 
higher number of clinics providing ART is off-set by more manageable patient numbers 
(Boulle & Coetzee, 2006). In the context of a global health worker crisis, this approach is 
vital to reaching the high number of people needing ART (WHO, 2007). 
 
Currently, the number of patients on treatment in the public sector in South Africa is only a 
small proportion of those who need it. This means that treatment programmes will need to 
expand rapidly if they are to narrow the treatment gap. The continued enrolment of patients 
on treatment will require considerable injections of staff if the same level of care is to be 
maintained. The Khayelitsha programme demonstrates that rapid expansion is possible 
without compromising clinical outcomes if the right skill mix is present. In Khayelitsha, the 
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patient load in three clinics has increased from 1500 consultations a month to 7000 
consultations a month in three clinics between 2001 and 2004. In that period, the proportion 
of patients who sustained viral loads below 400 copies per ml has increased from 87.1% to 
92.8% (Boulle & Coetzee, 2006).  
 
While there has been some increase in the number of staff within the service, the increases 
are considerably smaller than the requirements set out in the CCMT Plan. Similarly, as the 
demand for ART increases, there is a risk that other HIV-related services will be crowded 
out due to the reallocation of staff, and constraints in space and available human resources. 
This poses great risk to achieving adherence, viral load suppression and prolonged life. It is 
imperative that these services continue to be strengthened in order that there is continuity of 
care and to ensure that patients are kept within the health system. It is likely that integrating 
and strengthening VCT, TB and PMTCT services will result in these services being able to 
absorb some of the additional patient load until patients qualify to start ART. 
 
Already, scarce skills personnel in sites that are approaching saturation are reporting that 
they do not have sufficient time to spend with patients. In the words of a pharmacist in 
Gauteng “It’s very, very strenuous… Very often we have to be fast in our dispensing 
mechanisms and sometimes patients don’t get the best quality out of our service. We are 
pushed for time.” (Bodibe, 2006) 
 
This pharmacist spends five minutes with her patients and that is not ideal. By 11 o’clock, 
she has already seen 43 patients and more than 50 are waiting.  “Under ideal circumstances 
that’s not how I want to be because pharmacy is a complicated issue, as you can imagine. It’s 
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medicine. So, it goes into a body. And it needs to be the correct dose, the correct strength. 
There are some finer details that you sometimes have to take time and explain to your 
patient. But you always have that burning issue at the back of your head: Time factor, time 
factor. Other people are waiting as well. Hurry up. Be fast. Be quick” (Bodibe, 2006). 
 
If patient interactions with the ART service are restricted to meeting with an over-burdened 
pharmacist to obtain a repeat of their medication, it creates little opportunity to foster and 
maintain productive provider patient interactions. If patients are unable to communicate 
their problems and concerns to their health care worker, it is more likely that they may 
interrupt treatment without accessing available support and resources to assist with 
adherence. This may result in a high number of premature deaths. If drug resistance 
develops, patients will need to be moved to more expensive drugs. This may result in fewer 
numbers of patients being able to access ART (McCoy et al, 2005).  
 
Similarly, many ART models assume that the time required per patient will decrease the 
longer a patient remains on treatment. While this creates potential for task shifting and 
turning over maintenance to staff nurses, there are risks in such an approach (Hirschhorn et 
al, 2006). Patients who have been taking treatment over an extended period may not remain 
adherent and second line regimen drugs are more clinically complex and require more careful 
management. This complexity may negatively impact adherence levels (Paterson et al, 2000). 
Though very few patients in Site A were on second-line regimen drugs and no  patients were 
on second-line regimen drugs in Site B, numbers are likely to increase over time and may 
impact levels of adherence considerably.  
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1.3 Aims and Objectives 
 
The aim of this study was to assess organisational capacity to provide ART within two 
CCMT sites in Gauteng and the impact of such capacity on levels of adherence to ART and 
retention in treatment programmes. 
The objectives were to assess: 
1. Levels of adherence and follow-up at two CCMT sites in Gauteng 
2. Dimensions of organisational capacity within the sites as defined in Wagner’s Chronic 
Care Model: 
• Patient-provider relationships (levels of motivation, workload, absenteeism, skills 
mix, staffing profile). 
• Delivery systems design (integration of services, continuity of care, lay-out of 
services, adherence management systems, patient education, relationships with 
other departments and community organisations). 
• Support systems (drug procurement and distribution, availability and use of 
relevant protocols and procedures, physical infrastructure, organisational 
structure and leadership). 
• Clinical information systems (capturing and recording of data, use of data to 
inform practice, monitoring and evaluation of programme performance). 
 
1.4. Definition of terms 
1. For the purposes of the study, adherence is defined as patients taking 95% of the required 
dosage in the preceding seven days. 
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2. Organisational factors can include, but are not limited to, staffing, administrative 
procedures, motivation levels, support systems, consistent availability of human and 
material resources and patterns of referral between services. 
3. Comprehensive Care, Management and Treatment (CCMT) refers to a basket of HIV-related 
services that includes PMTCT, VCT, Wellness and ART. 
4. Successful treatment outcomes are considered to be combating the development of drug 
resistance and the achievement of viral suppression. 
5. Task Shifting refers to the rational redistribution of tasks from highly qualified health 
workers to health workers with less training and fewer qualifications, in order to make 
more efficient use of available human resources. 
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CHAPTER 2 – METHODOLOGY 
 
2.1 Study design 
 
This study is descriptive and operational in nature. It compares and contrasts organisational 
capacity and levels of adherence in two, second generation CCMT sites providing care to 
people living with HIV/AIDS, including Anti Retroviral therapy in Gauteng, since 2004. 
These second generation CCMT sites were established in non-academic settings during the 
course of 2004. The two sites were typical of the initial public sector CCMT sites established 
post 2004, had sufficient time to overcome basic teething problems and had recruited a 
sizeable number of patients on treatment. The first was a regional hospital in Ekurhuleni 
(referred to as Site A) and the second was a Community Health Centre (CHC) in Sedibeng 
District (referred to as Site B). The study evaluated the functioning of each site and its 
existing systems and programmes that support adherence to ART and more generally, good 
outcomes of care.  
 
2.2 Study population 
 
This study focussed on CCMT sites providing ART to patients in Region B of Gauteng. 
Region B includes the Ekurhuleni Metropolitan Municipality and Sedibeng District 
Municipality. Site A and B are located within these two regions. Ekurhuleni Metro has an 
estimated population of 2 478 130, comprises 26% of the population of Gauteng, has a 44% 
unemployment rate and an average household size of 3.19 people per household (Statistics 
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South Africa, 2003). Antenatal Survey Data collected in 2006 records the HIV prevalence 
among ANC attendees in Ekurhuleni Metropolitan District as 32.3%. Sedibeng District had 
an estimated population of 796 760, comprises 9% of the population of Gauteng, has a 
40.4% unemployment rate  and an average household size of 3.45 people (Statistics South 
Africa, 2003). Antenatal Survey Data collected in 2006 records the HIV prevalence among 
ANC attendees in Sedibeng district as 35%. This is the highest ANC prevalence data in 
Gauteng. The household size and unemployment rates are not dissimilar to each other. Both 
sites are located in urban areas. At the time of the study, six CCMT sites in Region B met the 
study criteria as second generation public sector sites. Within the sites, this study is 
concerned with two populations. The first, and the primary focus of this study, were health 
care workers employed in the CCMT service and the systems to support them; and the 
second, were patients attending the CCMT service. Quantitative and qualitative data was 
triangulated to develop a thorough assessment of organisational capacity and adherence in 
both sites. 
 
2.3 Study sample 
 
Two CCMT sites in Region B were randomly selected as part of a sampling process for a 
larger study of both Regions A and B in Gauteng. Thirteen CCMT sites in the two Regions 
met the inclusion criteria as second generation sites, and were divided into Hospital and 
Community Health Centre-based sites. Two sites were randomly selected from each stratum, 
two of which happened to fall within Region B. Within the sites the sample selected for this 
study included firstly, facility staff employed in HIV-related services and, secondly, patients 
attending the ART clinic in both sites. Managers responsible for the following 
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services/positions were interviewed: Ante-Natal Care and Prevention of Mother-to-Child-
Transmission (ANC/PMTCT), TB, VCT, ART services and the Facility Manager. All the 
health workers working in these various services were also invited to complete an 
anonymous self-administered questionnaire (SAQ). This questionnaire focussed on issues of 
motivation, workload, absenteeism and perceptions of individual risk of HIV infection 
within their work environment. All research instruments are included as an annexure to this 
report. 
 
Patients were recruited for interviews through systematic sampling. Patients were 
approached sequentially over a one-month period by fieldworkers in each site and asked 
whether he or she was willing to participate in an interview. The patient files of interviewees 
were also reviewed.  
 
Table 1: Sample size in Sites A and B 
 
Measurement Site A (n) Site B (n) 
Interviews with unit managers 5 5 
Self-Administered Questionnaires completed 11 24 
Patients interviewed and files reviewed 191 164 
 
2.4 Conceptual framework 
 
Using the Wagner model as the basic template for the fieldwork, data collection was 
organised into themes. These themes are (1) adherence outcomes, (2) motivated and 
adequately staffed teams, (3) delivery systems design, (4) decision support and (5) clinical 
information systems. The data collection involved a number of processes and instruments. 
Semi-structured interviews with staff provided information about staffing within each unit, 
levels of training, and staff losses since the initiation of the ART service, movement of 
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patients through the CCMT service, management of patients with HIV, specific training 
received by staff to support the delivery of ART, task allocation among different categories 
of staff, record-keeping and administrative procedures. Questions were also asked regarding 
the collection and use of information within the CCMT service. Where possible, gaps in 
information were addressed by examining available routine data. Health workers in both sites 
were provided with an SAQ to complete. The instrument asked questions relating to 
motivation and burnout. 
 
Exit interviews with patients elicited information regarding socio-economic status, the 
movement of patients within the health system, sources of support, experiences of health 
workers in each site and reasons for missing treatment. This report looks specifically at data 
items pertaining to factors that affect adherence and reasons for missing treatment. 
 
Routine data provided information about staff training and workload information as well as 
facility-level and service-specific data. Data items included the number of patients seen 
within the facility,   including the number of new patients and the number of patients who 
were lost to follow-up. Facility-level data included staff absenteeism rates, workload 
information,  patient headcounts and service-specific data from the ANC, PMTCT, TB, 
VCT and ART services within each site. Service-specific data included the number of HIV 
tests taken, the number of CD4 counts performed, the number of patients started on TB 
treatment and the number of patients registering for PMTCT within the ANC service. This 
data was obtained from Facility Managers and the head nurses within each service.  
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A third source of data was derived from the researcher visiting each of the sites and 
recording general observations about resources and facilities within the CCMT service, 
patient-provider interactions, quality of the working environment, the capacity and integrity 
of systems to cope with demands placed on them and referral procedures between units and 
within the site itself. These observations were recorded as observations in a diary. 
 
Reliability was ensured through the use of standardised tools that consisted of predominantly 
closed ended questions and check boxes to capture information. The same tools were used 
in both sites and data collection was completed in both sites by the primary researcher. This 
ensured that observations were accurately reflected and could be consistently analysed and 
compared in both sites. All routine data was taken from written records that are stored in the 
CCMT Manager’s office and are recorded on Gauteng Department of Health forms. 
Consistency in understanding is reflected in the responses provided during interviews. 
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Table 2: Measurement and data sources for domains evaluated (Adapted from Schneider et al, 2008). 
Domains Measurement Data sources 
(1) Outcomes 
Self reported adherence 3 day recall, ever missed tablets or appointments Patient exit interviews 
Viral load suppression, CD4 count <400 copies/ml; CD4>200 Record reviews 
Retention in care Defaulters; transfers; deaths  Routine facility data obtained both on 
site and centrally 
(2) Prepared proactive practice teams 
Adequately staffed teams Staffing relative to norms set by CCMT Plan; turnover; 
vacancy rates; workloads 
Facility and CCMT Manager 
interviews 
Provider motivation  23 item tool assessing motivation, determinants and outcomes  Self administered questionnaires 
Productive interactions Researcher observations, patient perceptions Observations and patient exit 
interviews 
(3) Delivery systems design 
Service integration  Presence of clear care pathways, assessments of integration  Facility, CCMT Manager interviews 
and facility observations 
Referral and networking 
relationships 
Presence of referral relationships between services, NGOs  CCMT Manager interviews 
Adherence Management Systems Methods of treatment preparation, maintaining adherence and 
tracing loss to follow-up 
CCMT Manager interviews 
(4) Decision Support 
Equipment and physical 
infrastructure 
Presence of essential equipment and infrastructure  Facility checklists 
Drug procurement and distribution Drug supply system, presence of essential drugs CCMT Manager interviews and facility 
checklists 
Laboratory capacity Ability to do essential laboratory tests, turn around times CCMT Manager interviews 
Guidelines, policies and protocols Availability of guidelines, policies, protocols CCMT Manager interviews and facility 
checklists  
(5) Information Systems 
Clinical records, Mechanisms for 
tracking clinical outcomes;  
Structured to allow for clinical monitoring, registers to track 
drop outs  
Facility observations and CCMT 
Manager interviews 
Programme monitoring  Structured systems, use of data locally, reports and feedback, 
electronic vs. paper based 
Facility observations and CCMT 
Manager interviews 
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2.5 Data analysis and management 
 
The process of data analysis involved bringing together various sources and types of data to 
develop a composite picture of each site and to identify areas of similarity and relationships 
between data elements.  This process is referred to as triangulation. In this study, 
triangulation involved combining information provided by health workers and by patients, 
with routine data recorded at central level and then comparing the perceptions of facilities, 
patients and health workers. 
 
Similar questions were asked to the head of each service. This assisted in creating a 
comprehensive picture of the way the health system works in each site. Questionnaires 
completed by staff provided a picture of the relationships among staff, perceptions of 
management and individual attitudes towards work. These were compared across sites and 
with information provided during interviews with the heads of each service. Areas of 
similarity and difference across sites were analysed further. 
 
2.6 Ethics 
 
Strict ethical guidelines were followed while completing data collection. All health care 
workers who were interviewed or completed an anonymous SAQ were provided with a 
description of the study and an opportunity to ask questions, and were required to sign an 
informed consent form. The consent form outlined their conditions for participating in the 
study. All were anonymous and no analysis of individual department dynamics was 
performed. The questionnaires provided a generalised picture of motivation, attitudes and 
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relationships within each site. Facility codes and patient numbers were used to ensure that 
data remained confidential. No personal names or identifying information of any participant 
was recorded. 
 
Patients who participated in the study were voluntarily recruited and were asked to provide 
written consent to be interviewed and to have their files reviewed. Data collected during exit 
interviews with patients was recorded using the unique identifying patient number. No 
individual names were used on any instruments. This ensured confidentiality. 
 
2.7 Limitations 
 
The data was collected in October 2006 and it is likely that the treatment programme in each 
site may have evolved differently. Difficulty obtaining comprehensive routine data in Site A 
also made it difficult to comprehensively assess levels of adherence in Site A. Nurses 
interviewed who were working in the TB service did not seem to have a grasp of  core data 
items such as the TB cure rate within each facility and the number of patients co-infected 
with TB and HIV.  
 
This made it somewhat difficult to make a thorough assessment of the integration of services 
with the CCMT clinic at Site A. There was a low response rate to the SAQs circulated in 
both sites. These tools were circulated more than once with a low return rate. This may point 
to staff being overloaded with work and possible respondent fatigue. The competing 
demands of patient care, reporting requirements and constraints in physical space made it 
difficult to complete interviews without interruptions.  
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Interviews with CCMT and Facility Managers took in excess of 90 minutes (including 
verification of routine data) a considerable proportion of the working day. The CCMT 
Manager in Site A was also engaged in some clinical duties herself. In both sites, the main 
telephone was located in the CCMT Manager’s office and there was frequent traffic in and 
out the office to make and receive calls. This limited privacy. 
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CHAPTER THREE – RESULTS 
 
Results will be presented in four sections. These four sections correspond with the domains 
identified in Wagner’s Chronic Care Model. Each domain will be discussed individually and a 
comparison of findings in the two sites will be provided.  
 
3.1 Overview of sites 
 
Two roll-out sites within the Region B health district of Gauteng were selected for this 
research (Table 3), the first site being a regional hospital situated in the Ekurhuleni municipal 
jurisdiction of Gauteng. The hospital has a capacity of 784 beds and has provided ART since 
July 2004. The second site is a CHC located in the Sedibeng municipal jurisdiction and has 
been providing treatment since October 2004. The CHC provides outpatient services and 
has started 804 patients on treatment since October 2004. By September 2006, 584 patients 
were still on treatment and there was no waiting list. Both sites are headed by professional 
nurses with prior experience in the administration of ART.  
 
Interviews and observations were conducted with the same departments in both sites and 
SAQs completed by health staff working within the CCMT service. Despite there being 
significantly more patients receiving treatment in Site A than Site B, a total of 2038 
compared to 585, only eleven SAQs were completed in the hospital and twenty four 
questionnaires were completed by staff at the CHC.   
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Table 3: Profile of Sites Studied 
 
SITE A SITE B 
GENERAL PROFILE 
• Provincially run regional hospital, falling within the Ekurhuleni 
municipal jurisdiction of Gauteng. 
• The average amount spent on transport to attend one clinic visit 
was R14 and R11 on food (R25 in total). 
• 39/191 (20.4%) patients had conducted any economic activity in the 
two weeks prior to attending the clinic.   
• 100/191 patients (52%) are receiving a disability grant. 
• Provides both outpatient and inpatient care. 
• Outpatient hours: 7am – 4pm (Monday to Friday). 
• Provincially run CHC falling within the Sedibeng municipal 
jurisdiction of Gauteng 
• Average cost incurred by patients per visit is R12 for transport 
and for R6 for food (R18 in total). 
• 31/163 respondents (19%) had engaged in some form of 
economic activity in the two weeks prior to being interviewed.   
• 71/164 (43%) are receiving a disability grant. 
• Only provides outpatient care. 
• Opening hours: 7am - 4pm (Monday to Friday). 
HIV RELATED SERVICES ASSESSED 
• Outpatient Department 
•  VCT Service 
• TB Focal Point 
• ANC/PMTCT 
•  CCMT service 
• VCT Service 
• TB Focal Point 
• ANC/PMTCT 
• CCMT service 
 
 
PROFILE OF CCMT SITES 
• Operational since July 2004 
• ART Clinic: Monday-Friday 
• New patients are seen on Fridays  
• No wellness programme within site due to lack of space and staff  
• 2038 initiated on ART since July 2004 (central data) 
• 357 patients waiting to start treatment 
• Average of three months between completing adherence 
counselling and starting treatment 
• Operational since  October 2004 
• Physically integrated with CHC 
• ART Clinic Monday-Friday 
• Wellness and Follow up: integrated into clinic services 
• Friday: Administration and enrolment of new patients 
• 804 initiated on ART since October 2004  (data from Facility 
Manager) 
• Are still on ART in this service – 584 as at September 
2006(73%) 
• No waiting list 
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3.2 Adherence as an outcome 
 
Adherence to treatment can be measured in a number of ways. One of the primary methods 
for determining adherence to ART among patients is by monitoring the CD4 count and viral 
load of patients taking ART. While this is generally accepted as the most appropriate clinical 
measure of adherence, it can not be assumed that high levels of adherence will result in an 
improved CD4 count and a decreased viral load. 
 
Table 4: Record of viral load suppression among patients on ART 
  
 
Hospital (Site A) Community Health 
Centre (Site B) 
Total patient interviews 191 164 
Total with viral load result 158 (83%) 110 (67%) 
0-399 (Undetectable) 139  99  
>= 400 19 11 
 
Information pertaining to viral loads and CD4 counts was available in both sites, with only 
three patient files being incomplete at Site A and one patient file missing at Site B.   
 
In Site A, data pertaining to drop-outs and transfers out of patients was incomplete and was 
said, by the CCMT Manager, to be unreliable. Data provided by the Facility Manager at Site 
B was complete and up-to-date. The distinction between patients who were recorded as lost-
to-follow up and transfers out however, was not clear and consistent in both sites. In Site A, 
the pharmacist was responsible for recording patient information when a patient had not 
arrived for their scheduled appointment. If the patient arrived on an alternative day, they 
were not turned away and a repeat of their medication would be issued. This would mean 
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that the patient was no longer lost to follow-up. This raises questions about the validity of 
this indicator.  
 
Table 5: Adherence Patterns in Sites A and B 
 Site A  Site B 
Total interviewed 191 164 
Missed scheduled appointment 31 (16.2%) 18 (10.9%) 
Missed appointments but did not miss dose 28 14 
Missed appointments and dose 3 4 
Missed tablets  in last three days 0 0 
Missed tablets in last week 2 4 
Missed tablets in last two weeks 4 5 
Missed tablets in last three months 4 2 
Missed tablets more than three months ago 10 13 
Ever missed dose 20 (10.5%) 24 (14.6%) 
Never missed tablets 171 140 
Adherence levels (89.5%) 
 
(85.4%) 
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Figure 4: Comparison of adherence patterns in Sites A and B 
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The data indicated that non-adherence to treatment could not be solely explained by failure 
to attend scheduled appointments. Factors such as continuity of care, attendance at support 
groups, workload and staffing, use of routine data and integration of services and their 
possible impact upon levels of adherence will be explored in further detail in the sections 
that follow. 
 
3.3 Prepared proactive practice teams 
 
The existence of prepared proactive practice teams forms a major component of Wagner’s 
Chronic Care Model. This component will be looked at in more detail by focusing on each 
of the core elements in detail below.  
 
3.3.1  Staffing in each site 
Healthcare workers form the backbone of the health care system. The training and 
experience of health care workers, their workload and levels of motivation impact 
significantly upon the quality of care provided to patients. In this study, the quality of 
relationships between patients and staff differed between sites. At Site A, it was very clear 
that the staff knew many patients by face and interacted with patients comfortably in the 
public waiting area. Similarly, patients approached staff and chatted informally outside of the 
consultation room in Site A. There was a generally positive atmosphere in the clinic. The 
CCMT Manager had been working within the ART clinic at Site A since its inception in 
2004. 
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In contrast, there had been three different CCMT Managers working in the ART service at 
Site B since inception of the programme. The current CCMT Manager at the site stated 
during the interview that these changes had a negative impact upon the patient-provider 
relationship because patients had to start getting to know a new person. Very little 
interaction between patients and staff within the clinic was observed at Site B. However, 
when patients were asked about their relationships with health care workers, 96% of patients 
at both sites (183/191 and 158/164 respectively) agreed with the statement that health care 
workers care about them.  
 
In Site A, 98% of patients interviewed (186/190) agreed with the statement “When I need to 
obtain other care that they cannot provide in this clinic, I was given enough help to get to 
the right place.” Similarly, of the 164 patients interviewed at Site B, 93% (153/164) agreed 
with the statement. These high scores may be interpreted to mean good patient-provider 
relationships and well-functioning pathways of care. Despite contrasting observations by the 
researcher, exit interviews with patients generated similar responses to questions about 
patient-provider interactions. The observations may not fully reflect the patient experience. 
Responses during interviews with patients may be affected by a desirability bias, introduced 
when participant responses are guided by what they perceive to be the good or right answer. 
In this instance, patients may have suggested that their relationship with health care 
providers is good as they were not familiar with the interviewer and less likely to share their 
ideas and opinions openly. 
 
The CCMT Plan puts in place core requirements to be met prior to any health care facility 
being accredited to provide ART to patients. This plan proposes very clear minimum staffing 
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requirements per 500 patients on treatment (Table 6). Accreditation is based on an 
anticipated 500 person patient load.  
Table 6: Core Staffing Requirements per Service Site to Treat 500 Patients on ART 
Category of staff Minimum (Full-time) 
Medical Officers 1 
Professional Nurses 2 
Pharmacists 1 
Dieticians/Nutritionists  1 
Social Workers 1 (Part-time) 
Lay Counsellors 5 
Administrative Clerks 1 
Data Capturers 1 
Total 12.5 
 
Table 7 represents the actual staffing situation within the sites included in this study and 
compares this against the proposed staffing capacity that is outlined in the CCMT Plan. It is 
evident that not only were some positions vacant within both sites, but also that the number 
of available posts within each category did not correlate with the minimum requirements as 
stipulated in the CCMT Plan (Table  6). 
 
Failure to meet the minimum staffing requirements seemingly impacts on patient care. The 
full-time pharmacist is quoted in Site A as having said “Often we have to be fast in our 
dispensing mechanisms and sometimes patients don’t get the best quality out of our service. 
We are pushed for time […] that’s not how I want to be, because pharmacy is a complicated 
issue. There are some finer details that you sometimes have to take the time to explain to 
your patient. But you always have that burning issue at the back of your head: time factor, 
time factor. Other people are waiting as well, Hurry up. Be fast. Be quick (Bodibe, 2006).” 
The data below was collected during interviews with Facility Managers in both sites.  
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Table 7: Comparison between staff required per site in line with Operational Plan compared to staff available in CCMT sites at time of 
data collection 
 
Regional Hospital (Site A)  Community Health Centre (Site B) 
Staff No. 
staff 
(req’d) 
No. 
Staff 
(actual) 
Shortage/ 
Surplus 
Vacant Left in 
last  
12 
months 
Joined  
in last  
12 
months 
 No. 
staff 
(req’d) 
No. 
staff 
(actual) 
Shortage/ 
Surplus 
Vacant Left in  
last 12  
months 
Joined 
in last 
12 
months 
Medical 
Officers 
4 2 -2 (FT) Doesn’t 
know 
 1  1 (FT) 
1 (PT) 
2 (PT) -1 (PT)  1 (FT) 1 (PT) 
Nurses 12 6 -6 (FT) 2  3 (1 
retired) 
 3 (FT) 2 (FT) -1 (FT)   1 
Enrolled 
Nursing 
Assistant 
 -       1     
Lay 
Counsellors 
20 5 -15 (FT) 1 3 2  7 (FT) 
1 (PT) 
5 (PT) -5 (FT)    
Volunteers  -            
Dieticians 4 1 -3 (FT)     1 (FT) 
1 (PT) 
 -1 (FT) 1  1 
Social 
Workers 
2 1 -1 (FT)     1 1     
Psychologist  1       -     
Clerical staff  4 2 -2 (FT)      1     
Cleaning 
staff 
 1       1     
Pharmacy 
Assistant 
 1            
Pharmacist 3 1 -2 (FT)     1 (FT) 
 
1 (PT) 
1 (PT) -1 (FT) 1 1 (FT) 1 
Data 
capturer 
4 1 -3 (FT)     1 1     
 
  40 
By September 2006, Site A had 2038 patients and Site B had 804 patients registered on 
treatment. If this formula of core staffing requirements was applied for Sites A and B, the 
staffing component required would be considerably higher than that available. Despite these 
gaps, staffing data demonstrated that the number of staff that joined both sites was higher 
than the number that left. 
 
As no other ART site had been initiated within the broad catchment area of Site A, it had 
become very difficult for Site A to keep up with the number of patients waiting to begin 
treatment. The Facility Manager felt very strongly about the need to down refer stable 
patients to primary health care clinics so that Site A could expand the treatment programme 
and address some of the capacity issues that the site is currently facing.  
 
3.3.2 Institutional arrangements relating to the role of lay counsellors in the ART 
service 
Identified NGOs received funding from the Department of Health to provide training to lay 
counsellors who were based at identified clinics and hospitals. Information as to the nature 
of training provided to lay counsellors within each service was not very comprehensive. This 
may have been due to the institutional arrangements where lay counsellors were trained, 
employed, managed and paid by external NGOs. This arrangement was not working 
smoothly in both sites included in this study. 
 
Khomanani, South Africa’s government sponsored HIV/AIDS education programme, 
provided counsellors to Site A. These counsellors were working in the ANC section, 
providing VCT, conducting drug literacy training and treatment education. The CCMT 
Manager in Site A indicated that counsellors were not always willing to follow instructions 
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provided by staff within the CCMT service as they ‘were not working for the hospital’ and 
the site was not responsible for the payment of stipends to volunteers and lay counsellors. 
During some months, NGOs did not pay the stipends timeously. This resulted in low levels 
of motivation and morale and, in certain instances, counsellors did not report for work 
because they had not received their stipend. This was in part attributed to the transport costs 
that counsellors incur to attend work.   
 
3.3.3 Health worker motivation 
In both sites, health workers working in HIV-related services were provided with an 
anonymous SAQ that probed issues of motivation, workload, organisational structure, 
relationships within and commitment to the facility in which they worked. Professional 
nurses, enrolled nurses, pharmacists, counsellors and health promoters completed the 
questionnaires. 
 
Eleven SAQs were completed at Site A and 24 SAQs were completed at Site B. Site A had 
more than three times the number of patients on treatment to Site B at the time of 
completing fieldwork. Although the number of SAQs filled in at each site did not correlate 
to the size of the treatment programme, when analysing the data it appeared that there were 
many areas of congruence across the two sites. 
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Table 8: Self reported motivation of health care workers in HIV-related services in Sites A and B 
 
Statement Site A Site B 
 Disagree Not 
Sure 
Agree 
 
n Disagree Not 
Sure 
Agree n 
Overall Motivation         
Overall, I am very satisfied with my job 1 (0.09) 1 
(0.09) 
9 (0.81) 11 4 (0.17) 2 (0.08) 17 (0.74) 23 
I am motivated to carry out my duties 1 (0.09) 0 10(0.9) 11 6 (0.25) 3 (0.13) 15 (0.62) 24 
I only do this job so that I get paid at the end of the 
month 
8 (0.72) 2 
(0.18) 
1 (0.09) 11 21 (0.91) 1 (0.04) 1 (0.04) 23 
 
I feel I’m positively influencing other people’s lives 
through my work 
0 0 11 (1.0) 11 4 (0.17) 1 (0.04) 19 (0.79) 24 
The major satisfaction in my life comes from my 
work 
4 (0.36) 1 
(0.09) 
6 (0.54) 11 10 (0.43) 0 13 (0.56) 23 
These days I don’t feel motivated to work as hard 
as I could 
5 (0.45) 1 
(0.09) 
5 (0.45) 11 8 (0.35) 2 (0.08) 13 (0.57) 23 
Organisational loyalty and commitment         
I am proud to be working at this clinic/hospital 0 2 
(0.18) 
9 (0.81) 11 1 (0.04) 1 (0.04) 22 (0.92) 24 
I am glad I work for this facility rather than other 
facilities in this province 
1 (0.09) 1 
(0.09) 
9 (0.81) 11 2 (0.08) 5 (0.21) 17 (0.71) 24 
I prefer to work in the public sector than in the 
private sector 
1 (0.09) 2 
(0.18) 
8 (0.72) 11 4 (0.16) 1 (0.04) 19 (0.79) 24 
I feel very little commitment to this hospital or clinic 10 (0.90) 1 
(0.10) 
0 11 16 (0.69) 1 (0.04) 6 (0.26) 23 
I intend to leave this hospital 5 (0.45) 3 
(0.27) 
3 (0.27) 11 9 (0.5) 7 (0.39) 2 (0.11) 18 
I can see myself working overseas in the future 5 (0.45) 3 
(0.27) 
3 (0.27) 11 13 (0.56) 4 (0.17) 6 (0.27) 23 
Workload and staffing         
The amount of work I have to do is too demanding 3 (0.27) 2 
(0.18) 
6 (0.54) 11 9 (0.37) 2 (0.08) 13 (0.54) 24 
There are enough staff to do the work in this unit 7 (0.63) 0 4 (0.36) 11 17 (0.71) 3 (0.12) 4 (0.16) 24 
Burnout         
I feel emotionally drained at the end of every day 2 (0.20) 1 
(0.10) 
7 (0.7) 10 5 (0.22) 5 (0.22) 13 (0.57) 23 
Management and teamwork         
Hospital/clinic management communicates well with 
staff in this site/hospital 
1 (0.1) 4 
(0.4) 
5 (0.5) 10 4 (0.18) 2 (0.09) 16 (0.73) 22 
If I had a personal problem which affected my work 
I would feel free to discuss it with my supervisor or 
manager 
1 (0.09) 2 
(0.18) 
8 (0.72) 11 6 (0.26) 4 (0.17) 13 (0.57) 23 
In this facility conflict hampers our work 6 (0.66) 1 
(0.11) 
2 (0.22) 9 18 (0.78) 3 (0.13) 2 (0.09) 23 
There have been too many changes at this hospital 
/clinic in the past year 
6 (0.54) 1 
(0.09) 
4 (0.36) 11 3 (0.14) 2 (0.09) 17 (0.77) 22 
In the last month, have any of your colleagues been 
unexpectedly absent from work? 
8 (0.73) 0 3 (0.27) 11 15 (0.63) 2 (0.08) 7 (0.29) 24 
Individual/ Personal factors and attitudes         
I am confident about my ability to do my job 0 0 11 (1.0) 11 0 0 24 (1.0) 24 
I feel vulnerable to HIV in my personal life 4 (0.36)  7 (0.64) 11 8 (0.35)  15 (0.65) 23 
HIV positive patients make too much extra work for 
staff 
6 (0.6) 1 
(0.10) 
3 (0.3) 10 18 (0.75) 1 (0.04) 5 (0.20) 24 
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3.3.4 Overall Motivation 
All respondents in both sites (11/11 in Site A and 24/24 in Site B respectively) agreed with 
the statement “I am confident about my ability to do my job”. In Site A, 9/11 (82%) 
respondents agreed with the statement “I am motivated to carry out my duties” while only 
15/24 (62%) CHC respondents agreed with this statement. This suggests differences in the 
levels of motivation between sites. The statement “These days I don’t feel motivated to work 
as hard as I could” elicited divided responses in both sites. An equal number of respondents 
(5/11) at Site A agreed or disagreed with this statement. This is different to the initial 
responses to the statement “I am motivated to carry out my duties” where 9/11 (82%) 
respondents agreed with this statement.  
 
3.3.5 Organisational loyalty and commitment 
Loyalty and commitment differed somewhat between sites. The statement “I am proud to be 
working at this facility” elicited 9/11 (82%) affirmative responses at Site A, and 22/24 (92%) 
respondents at the CHC agreed with this statement. Similarly, 9/11 (82%) respondents in 
Site A responded positively to the statement “I am glad I work for this facility rather than 
other facilities in the province” and 17/24 (71%) responded positively. There was 
unanimous disagreement at Site A with the statement “I feel very little commitment to this 
hospital” while 6/23 (26%) respondents at the CHC agreed with this statement. This draws 
attention to the difference in levels of loyalty across facilities.  
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3.3.6 Debriefing 
The number of respondents who indicated they felt emotionally drained at the end of the 
working day was greater in Site A than Site B. The lack of emotional support for staff 
emerged as a common theme throughout the in-depth interviews. During interviews, staff in 
both sites raised the irregularity with which debriefing is made available and in Site B, the 
provision of debriefing and the availability of psycho-social support to staff was dependent 
on whether sufficient budget was available to pay for this service. When money was available 
in the budget, debriefing would be conducted by external NGOs contracted to provide this 
specific service. This would usually happen on a quarterly basis.  
 
Staff in both sites reported that their patients problems become their own and that they 
found it difficult to work within the CCMT service over the longer-term due to the 
emotional burden of working with such a vulnerable population. Notably, 7/10 (70%) 
respondents (to the SAQ) in Site A indicated that they felt emotionally drained at the end of 
every day. In Site B, 13/24 (57%) agreed with this statement, with 21% (5/24) reporting they 
disagreed and 21% (5/24)  were unsure. In both sites A and B, 54% of respondents agreed 
that the amount of work they had to do was too demanding. 
 
3.3.7 Management and teamwork 
In Site A, 5/10 (50%) respondents responded affirmatively to the statement “Hospital/clinic 
management communicates well with staff in this site/hospital” compared to 16/22 (73%) 
respondents at the CHC. The proportion of respondents at Site A that agreed with the 
statement “There have been too many changes at this hospital /clinic in the past year” was 
greater than those at Site B. Interestingly, levels of change and staff turnover are higher in 
Site B. Trust in management was higher in Site A than in Site B. 
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3.3.8 Individual/ personal factors and attitudes 
The majority of staff at both sites indicated that they felt vulnerable to HIV in their personal 
lives. More than half of respondents in both sites disagreed with the statement “HIV 
positive patients make too much extra work for staff” (6/10 in the hospital and 18/24 in the 
CHC respectively).  
 
Despite the large difference in the number of patients on treatment and the number of staff 
working in the CCMT service at both sites, there were many areas of similarity in responses. 
Staff in both sites identified strongly with the facility in which they worked. The most 
obvious differences between sites pertain to levels of motivation and organisational change.  
 
3.3.9 Training and Skills Development 
Levels of training were assessed for all HIV-related services and significant differences in 
training between sites were identified. Staff at Site A had received extensive training on 
complex clinical aspects of administering ART. Many of these content areas were not 
identified by staff interviewed at Site B. Levels of training also varied across services within 
the same facility. Notably, staff interviewed within each service did not have full information 
as to the levels of training within their own unit as this information tended to be kept by the 
Facility Manager and was used to inform who should be identified to receive training in 
specific areas. Training tended to be done on a rotational basis so as not to affect the 
functioning of services. This meant that it took considerably longer to train and skill staff to 
be fully prepared to work in the CCMT service. 
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Table 9:  Levels of training as reported by CCMT Managers in Sites A and B 
 Site A Site B 
Staff n Content n Content 
Doctors 1 HIV/AIDS,  ART,  2 ART, PMTCT, 
counselling, HIV & AIDS 
Nurses 4 HIV/AIDS, PMTCT, ART, 
Management of Discordant 
couples, Pharma-
covigilance 
1 HIV & AIDS, counselling, 
CCMT 
Lay counsellors/volunteers 5 three day training on ART, 
Pre and Post Test 
counselling, Prevention 
5 HIV & AIDS, 
Comprehensive 
HIV/AIDS, Counselling 
Clerical 2 ART, Data Management 2 Basic HIV/AIDS 
Pharmacist 1 ART 1 Comprehensive 
HIV/AIDS 
Pharmacy Assistant 1 ART (trained by TAC)   
Social Worker   1 Basic HIV/AIDS 
 
Unit Managers in the TB, VCT, and ANC services were asked which of their staff had 
received training in ART specifically. Table 9 provides information on content areas of 
training provided and is a general reflection of the training situation for each staff category. 
Not all staff in each staff category had received training in all the content areas listed. Nurses 
working within the TB service at Site A had received more training that staff within Site B. 
In Site A, two professional nurses and one DOTS supporter had received training in ART.  
 
In comparison, in Site B the only person who had been trained in ART was a sessional 
doctor working in the unit three times a week. In Site B, the TB service operates from 07h00 
to 16h00 daily and is managed by a staff nurse on a full-time basis. She was assisted by a 
professional nurse on certain days. The staff nurse had not attended any training about HIV 
or ART. This was of concern given the strong link between TB and HIV and the increasing 
emphasis being placed upon cross-referral of all TB and HIV patients for testing in each 
service.  
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The VCT service at Site A was staffed by five enrolled nurses, four lay counsellors, and one 
part-time professional nurse who were assisted by four volunteers. Of this staff component, 
only the part-time professional nurse and four lay counsellors had received any training in 
HIV. In Site B, the VCT service was staffed by one doctor who also held other clinical 
duties, two professional nurses who share other clinical duties and two lay counsellors. In 
this site, the counsellors (who are responsible for the day-to-day running of the service) 
indicated that, to their knowledge, they were the only staff who had received training in HIV. 
This training included topics such as pre- and post-test counselling, basic information about 
HIV/AIDS, couple counselling and a follow-up intensive course on HIV/AIDS.  
 
Staff in the ANC unit at Site A had received more training than those working in Site B. This 
may be explained by the greater patient load and higher demand for services in Site A. 
Professional nurses, enrolled nurses and counsellors had all received some training in 
HIV/AIDS. Difficulties cited by the CCMT Manager at Site A were people being trained 
and then transferred to another department and the difficulty of staffing departments when 
staff are released for training.  
 
Nurses and counsellors in the ANC unit at Site B had been trained in HIV. Both nurses and 
counsellors were trained in PMTCT and VCT. It was difficult to obtain any further 
information as to the length of the training and whether there were any differences in the 
content covered with these two groups. Information supplied by the ANC unit in Site B 
indicated that while nurses had received training on PMTCT, none had been trained on 
managing ART in pregnant women. This is problematic given the clinical complexity of 
working with pregnant women who are simultaneously taking ART. 
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3.4 Delivery systems design 
 
This component of the CCM speaks to operational arrangements within facilities. Some of 
the aspects covered during interviews with Unit Managers included referral processes and 
relationships between services, interaction with the surrounding community, and processes 
used to initiate, track and maintain patients on treatment. 
 
3.4.1 Integration of services and continuity of care 
The term integration is used to explain referral relationships and pathways of care. Facility 
and CCMT Managers as well as ANC providers were asked to rate the degree of integration 
of services within the facility in which they worked.  
 
Table 10:  Perceptions of integration within sites 
Site A Site B Statement 
Facility 
Manager 
CCMT ANC Facility  
Manager 
CCMT ANC 
A series of vertical activities 
completely separate from each 
other 
      
A series of activities partially 
coordinated with each other 
     √ 
A well integrated set of activities       
A well integrated set of activities 
that is also well integrated into 
the activities of the clinic/OPD 
as a whole 
√ √ √ √ √  
 
There was unanimous agreement among Unit Managers at Site A that services were well 
integrated within the facility. This is consistent with the observation that staff knew each 
other well and that services were located in close proximity to each other. This level of 
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integration was also facilitated by the fact that all staff within the unit reported to one central 
person. Statistics were submitted to the CCMT Manager who also oversaw the functioning 
of the TB, VCT and ANC services.  
 
One weak point in the continuity of care at Site A was the separation of duties between 
primary health care clinics and the hospital in relation to provision of TB treatment. Site A 
had a TB focal point where patients commenced treatment. Patients were then referred to 
primary health care clinics to be managed. An acknowledgement slip was provided to 
patients to take to the clinics. This slip should have been returned to the hospital. This did 
not always happen as clinics were frequently without drivers. For this reason, feedback on 
TB patients was predominantly done telephonically. PHC clinics were also responsible for 
follow-up of TB patients. It was said that the TB focal point did check that the patient 
reached the clinic but the site lacked the capacity to do any community-based follow up with 
patients who did not attend the PHC clinic to which they were referred. The focal point 
shared space with the VCT service. This allowed for easy referral between services. Patients 
who tested positive for TB are advised to go for VCT.  
 
When asked about referral procedures for patients who have TB and test HIV positive, a 
nurse working in the TB service at Site A indicated that patients often died while waiting to 
start ART, and that family members blamed staff working in the TB service for the delay 
between completing the treatment preparation process and initiating treatment. Similarly, a 
lay counsellor in Site A had the following to say: “I see many people die waiting for ARVs so 
sometimes I feel we are not doing enough to save them”. 
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In both Sites A and B, the protocol of starting a patient on TB treatment prior to initiating 
ART was followed. The Facility Manager in Site A reported that the CD4 count of patients 
who are co-infected with HIV and TB tended to increase once the patients were taking TB 
treatment, thus limiting the extent of the clinical side-effects likely to accompany early ART. 
In Site A, patients with HIV who are co-infected with TB and have a CD4 count of greater 
than 200 were referred to a wellness programme in the community and asked to return to 
the ART service at the site after 12 months, during which time patients should have 
completed TB treatment. This created fragmentation in the delivery of consistent high-
quality responsive patient care. 
 
In Site B, the screening, initiation and ongoing follow-up of patients taking TB medication 
took place within the facility directly. This made the monitoring and follow-up of patients 
registered in the CCMT service far less complex. Similarly, patients who were found to have 
a CD4 count greater than 200 were referred to the wellness programme that was run within 
the facility. In Site B, one professional nurse worked across the TB, ART and wellness 
service. This should mean that she had some clinical knowledge of the patients who were 
obtaining services at different points and their particular needs and problems. The services 
were all located within one main building. Staff members who were interviewed within each 
service indicated that they accompanied patients personally to their point of referral. As all 
services were located within one building in Site B, it was not a routine procedure to prepare 
referral letters. 
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Table 11: Views expressed by programme managers on integration of HIV-related services 
HIV related services Factors which facilitate integration Barriers to integration 
Regional Hospital (Site A) 
Facility Manager • ART service functioning every week day 
• VCT service well used 
• No drug stock outs 
• Shortage of pharmacists delays patients starting 
on treatment. The absence of a wellness 
programme contributes to high numbers of 
patients falling out of the system 
• Programme is saturated and is still treating 
patients who joined the programme in 2004. It is 
urgent that stable patients are down referred to 
PHC clinics so as to address the high waiting list. 
• Insufficient staff in the ART clinic 
• Having to use untrained staff to complete tasks in 
unit (Queue marshals assist in pharmacy and 
provide drug counselling) 
• Difficult to monitor number of patients still on 
treatment as many deaths not reported 
ART • High rates of self-referral for VCT allow for early 
intervention, education for behaviour change 
and delay the need to start treatment 
• Stability within facility with low turnover 
• Good teamwork and high levels of loyalty and 
commitment (described in detail in Table 8 
above) 
• Site covers a large geographical area – patients 
often lost to follow up 
• No wellness programme due to lack of space and 
staff – resulting in large fall-out of HIV+ patients 
• Not always continuity of care as doctors and 
nurses are overstretched 
• Difficulty of integrating patients from private 
sector into public sector due to different drug 
regimens used 
• Absence of a strong intensive monitoring system 
• Temporary stock out of paediatric drugs means 
patients had to return after one week for new 
repeats 
Voluntary Counselling 
and Testing (VCT) 
•  • Some patients who are HIV+ do not return to the 
hospital due to distance (do not have money for 
taxi fare) 
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HIV related services Factors which facilitate integration Barriers to integration 
TB service • Good cooperation among staff 
• Physical proximity of services 
• Long waiting lists means patients complete 
adherence counselling and can not commence 
treatment  
• Patients being referred to PHC clinics 
• Doctors test in-patients for TB and do not refer 
via focal point so hard to keep accurate records 
• Reliance on external volunteers and NGOs to 
track patients due to staff shortages and absence 
of a vehicle 
• Patients seen by doctors often do not return to 
focal point to get results and do not start 
treatment when necessary (Sputa taken by 
doctors directly, not within TB service) 
• Felt that it should be routine that all patients test 
for TB before starting ART. The high number of 
tablets patients take simultaneously (TB& ART) 
increases likelihood to default. 
• Lack of familiarity with data means data is not 
being used to track clinical outcomes, monitor 
uptake of services and movement within services  
Prevention of Mother-to-
Child Transmission 
(PMTCT) 
• Good referral between services 
• Patients bring partners for testing 
• Existence of support group for pregnant women 
• Patients without IDs cannot be enrolled on the 
treatment programme. These patients are also 
unable to get a CD4 count taken as this is done 
through the ART clinic 
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HIV related services Factors which facilitate integration Barriers to integration 
Community Health Centre (Site B) 
Facility Manager • Excellent data collection and capture 
• High levels of community involvement 
• ART service running daily 
• No patient is turned away from ART service for 
having come on the wrong day 
 
• Absence of regular debriefing increases levels of 
burnout 
ART • Area where ART provided is located in a quiet 
area behind closed doors facilitating 
confidentiality 
• Staff working in ART are not working in other 
units/areas 
• Regular drug supply, no problems with 
procurement or distribution 
• Good support from Facility Manager 
• Functioning community health committees 
• NGOs and Traditional Leaders who refer 
patients and assist with tracking patients 
• Lack of space within ART clinic resulting in some 
patients having to stand while waiting to be seen 
• Frequent change in CCMT Managers has 
negative consequences for patient-provider 
relationships. Patients lose confidence in ART 
staff and affects relationship building. Frequent 
loss of personal history and relationships when 
staff changes  
• Difficult to manage patients coming in from 
private sector who are started on second line 
regimen drugs 
VCT service • Effective use of routine data and information to 
inform service delivery 
• Passion and commitment of staff 
• Lack of feedback from ART service as to how 
patients are progressing 
• Erratic payment of salaries due to counsellors 
being contracted to and paid by NGOs 
TB service • Staff work across sections where necessary • Patients who are HIV+ placed on TB treatment 
by doctors without a confirmed TB diagnosis 
• Heavy administrative load for one person 
• Enrolled nurse staffing the TB service has not 
been trained in ART 
• Patients referred to TB service from outside CHC 
without a referral letter 
• Difficult to use computer to record data on TB 
patients as many come with incomplete 
identifying information 
ANC/PMTCT service • Health education programmes well-attended • Staff are shared between VCT and PMTCT 
• Difficult to track and follow-up patients 
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3.4.2 Adherence Management Systems 
Semi-structured interviews with CCMT Managers collected information about the 
process of treatment preparation in each site and the procedure for monitoring and 
tracking patients who were not adhering to treatment or had dropped out of the 
programme. The CCMT Manager was asked to map out the stages involved in 
determining whether a patient is ready to begin treatment and the role of each health care 
worker. Treatment preparation processes differed between facilities. This could be 
attributed to the difference in procedure that was followed when a patient received a 
positive HIV test result.  
 
Due to the high number of patients on treatment and the limited numbers of staff at Site 
A, no wellness programme existed within the site for patients who did not qualify for 
ART. These patients were down-referred to clinics for ongoing management and asked 
to return after twelve months or when they fell within the clinical criteria of a CD4 count 
below 200, whichever was sooner. All wellness, support group activities and DOTS 
support was done through clinics and organisations working in the area. The CCMT 
Manager was not familiar with these organisations. The reasons given for the lack of 
NGO involvement in the site was the lack of space. This was consistent with 
observations of the site. As there was no wellness service currently being run within the 
CCMT service itself, there was a risk that patients would not return.  
 
Site B had an active wellness programme that was run by a professional nurse with 
ongoing referral of patients from VCT to wellness and, at a later point, when necessary, 
referral to the ART clinic to commence treatment.  
 
 
  55 
 
Table 12: Treatment Initiation Rates in Sites A and B (April- October 2006) 
Number of patients 
started on treatment 
April May June July Aug Sept October 
Site A 34 58 74 81 111 213 175 
Site B 21 58 31 40 40 24 40 
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Figure 5: Treatment Initiation Rates between April and October 2006 in Sites A and B 
 
3.4.2.1 Treatment preparation in Site A 
The treatment preparation process began with three successive counselling sessions 
during which a detailed history was obtained from the patient. The history taking process 
looked at information such as family situation, employment status, social support and 
living conditions. The first counselling session was done by a lay counsellor and provided 
basic information and education about HIV, AIDS and ART. The following two 
counselling sessions were conducted by a nurse and focussed on the importance of 
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adherence, and drug training, including possible side-effects for each drug. Once the 
three sessions were completed, the patient was referred to the social worker for a 
thorough assessment. This assessment included sources of support and the living 
situation of the patient. Once the assessment was complete and the patient was found to 
be ready for treatment, they were referred to the dietician to begin supplements and 
vitamins. The shortage of social workers to conduct assessments was one of the reasons 
that patients who had completed treatment preparation were put on a waiting list prior to 
initiating ART. This meant that patients may have completed treatment preparation but 
could not start treatment until this assessment was complete. Considering that Site A had 
three times the number of patients on treatment, it was clear that there are not sufficient 
health care workers to do the work required in the ART service. In an attempt to address 
the long waiting list, treatment preparation processes were shorter in Site A than in Site 
B. Though this may have alleviated some of the backlog of patients, a bottleneck 
occurred where people had completed treatment preparation but were still facing delays 
in the initiation of ART.  
 
3.4.2.2 Treatment preparation in Site B 
The treatment preparation process at Site B was described by the Facility Manager in 
great detail. Once the patient’s CD4 count is below 200 and all opportunistic infections 
had been treated, the patient was referred for adherence counselling. This took place 
over three to four sessions, depending on the patient’s emotional status and readiness to 
begin treatment. Should it be necessary, patients were offered more counselling sessions. 
The Facility Manager explained that this was crucial as levels of concentration among 
patients with advanced HIV infection was often poor in addition to the difficulties 
caused by possible dementia associated with late stage AIDS. The adherence counselling 
was conducted by a lay counsellor. During the first visit, the nurse assessed the patient’s 
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nutritional status and, where necessary, the patient was referred to see the dietician. At 
the time of completing fieldwork, the position for a dietician was vacant. Since 
completing data collection, a full-time dietician had been employed at Site B. In the 
second session of adherence counselling, the patient’s level of understanding was 
assessed and the information covered in the previous session was recapitulated. The third 
session checked the sexual behaviour of the patient and support structures available to 
the patient. At this stage, baseline bloods were also collected – viral loads, full blood 
counts and liver function tests.  
 
Once the results were received, the patient was referred to the doctor for assessment and 
treatment was initiated. Throughout the treatment preparation process, the patient was 
able to see a registered nurse. In instances where the clinical prognosis of the patient was 
poor, the patients were referred to see the doctor at their first visit.  All patients were 
encouraged to bring a treatment buddy to the treatment preparation process. 
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Table 13: Methods and procedures used in treatment preparation and adherence 
support 
Tools and methods 
 
Site A (Regional hospital) Site B (CHC) 
Treatment preparation 
Individual counselling/briefing Yes Yes 
Group education Yes (dialogue with health 
worker) 
Yes – conducted by CCMT 
Manager where patients are 
provided with drug training. 
Talks conducted by 
Treatment Action Campaign 
on Tuesday and Thursday. 
Nomination of treatment 
buddy 
Yes Yes 
Home visit No, only in exceptions is a 
home visit conducted. If 
there is a dire need, the 
patient is referred to the 
social worker. The social 
worker is unable to conduct 
home visits due to a vehicle 
not being available 
Yes – Where patients do not 
keep appointments or a 
problem is identified, a home 
visit is made to the patient by 
the DOTS supporters from 
surrounding NGOs involved 
at the CHC 
Knowledge questionnaire No – the CCMT Manager 
indicated that this was not 
done as it would ‘make 
people uncomfortable’ 
Yes – done by doctor  
Consent forms or patient 
contract 
No – only used in obtaining 
consent for voluntary 
counselling and testing 
(VCT) 
Yes –contained in patient 
files  
Written information/pamphlets Yes – obtainable at the front 
desk 
Yes - Provided by 
Khomanani, the government 
sponsored health 
education/communication 
programme  
Treatment support 
Follow-up appointments Yes Yes 
Pill boxes No – to be provided by 
patients 
No – to be provided by 
patients 
Tick sheets Yes Yes 
Adherence assessment  
Self reported adherence 
(three or four day recall) 
Yes Yes 
Pill count Yes Sometimes – depending on 
availability of person to help  
Viral load monitoring Yes – done at baseline and 
two months after 
commencing treatment, then 
every six months after 
Yes 
Return for follow-up Yes Yes 
Managing defaulters 
Identifying patients who miss 
appointments 
Noted by pharmacist Noted by pharmacist 
Tracing patients Contact patient 
telephonically 
Done by NGOs 
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Interviews and observations demonstrated that there was greater structured NGO 
involvement in Site B. Patients in Site A tended to be down-referred for NGO support 
due to the lack of staff and resources within the site itself. The CCMT Manager in Site A 
indicated that all support groups for people taking ART were run in the community. 
Support groups focusing on disclosure of HIV status were hosted within the ANC 
service.  
 
Patients who tested positive for TB at Site A were started on treatment but down-
referred to clinics for follow-up. This means that DOTS supporters were located at clinic 
level and that Site A (hospital) did not have the access to DOTS supporters to assist with 
home visits and support, in the way that Site B had.  
 
Site B had a significantly smaller catchment area and patient load than that of Site A. In 
Site B, follow-up of patients taking TB treatment took place at community level and was 
conducted by DOTS supporters attached to three NGOs. The DOTS supporters also 
assisted with monitoring patients taking ART. The Facility Manager reported that such 
volunteers also brought chronically ill patients who required immediate medical attention 
directly to the clinic. The Facility Manager reported that the site had developed good 
relationships with traditional healers in the surrounding community. The traditional 
healers had received some training on HIV and the treatment of opportunistic infections. 
It was reported that subsequent to the training, traditional healers were also bringing 
patients who were very sick to the clinic for assistance. This was observed during a visit 
to the site. Mindset Health which provides health education through broadcast television 
materials in clinics and the Treatment Action Campaign (TAC) were providing drug 
education and counselling at Site B. 
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In exit interviews, more patients reported attending support groups in Site B than in Site 
A. In Site B, 30/164 belonged to a support group. The majority of these patients 
attended weekly meetings (51%). Of the patients on treatment who belonged to a 
support group, 29/30 had never missed taking any of their medication, while one of the 
30 had missed taking their treatment more than three months ago. This data draws 
attention to the powerful role that support groups can play in increasing adherence 
among group members. On the day that patients attended the support group, lunch was 
provided by an NGO.  
 
3.4.2.3 Management of patients who are defaulting on treatment 
Site A 
If it was found that a patient was not keeping their appointments and was missing their 
treatment, counselling was intensified. This was done by involving the family and 
treatment supporter when available. Patients were then referred to NGOs for follow-up. 
Patients who were identified as ‘chronic defaulters’ (interrupting treatment and habitually 
not keeping appointments or taking treatment as prescribed) were required to come for 
their treatment weekly. This is in contrast to adherent patients who attended the clinic to 
collect medication monthly. This was to ensure closer monitoring and to limit the length 
of time treatment was interrupted. The CCMT Manager stated that patients who formed 
part of this group did come weekly to collect treatment and did observe these new 
arrangements.  
 
Of the 190 patients interviewed at Site A, 20 patients had missed their tablets since 
commencing treatment. The length of time the patients had missed their tablets in Site A 
ranged from 1 to 31 days. The most frequently cited reasons for people missing 
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treatment by these 20 patients was “people forget” (5/20) and “they drink alcohol” 
(4/20). “Because of the side-effects”, “being far away from home” and “don’t know” all 
scored the same number of responses (2/20).  
 
Site B 
All patients who did not arrive for their appointments were recorded by the pharmacist 
and step-up adherence measures were put in place. If there was an underlying problem, 
the patient was referred to the social worker. In the time since collecting the data at Site 
B, the social worker had resigned and by January 2007 the post had still not be filled. 
This made the provision of thorough adherence counselling and social support difficult. 
Of the 164 patient interviews conducted at Site B, 24 patients reported missing doses of 
their treatment since commencing ART. In Site B, the length of time that patients had 
missed taking their treatment ranged from 1 to 93 days. The reasons that were most 
frequently cited for patients missing treatment were “they forget” (6/24), “because of the 
side-effects” (5/24), “they are out of town” and “don’t know” scored the same number 
of responses (4/24). 
 
3.5 Decision support systems 
 
3.5.1 Physical infrastructure 
In both sites, all services were located within close proximity to each other and were 
within five minutes walking distance to each other. Both sites also had services which 
dealt with patients requiring post-exposure prophylaxis due to sexual assault. These were 
also in close proximity to other HIV related services. In Site B, all HIV related services 
were located within one main building. Just outside of the main entrance to the building 
was a youth friendly centre funded by Lovelife. The CCMT Manager regarded this as a 
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strength because it allowed youth to come forward for sexual health services without 
fearing they would be judged by clinic staff. Staff within the Lovelife clinic knew clinic 
staff well. This meant that should a person test positive for HIV, the referral process was 
smoother and easier.  
 
In both sites, the ART service was located in a very small physical space. While both 
units provided some measure of confidentiality to patients (by virtue of their location), by 
mid morning the waiting area was congested. In some instances, patients in Site A were 
standing due to a lack of chairs. This created a particular problem for patients who were 
heavily pregnant. The CCMT Manager and the nurse interviewed in the ANC unit both 
confirmed that this sometimes resulted in pregnant women not wanting to wait. 
  
In Site A, the ART clinic had been moved into an existing building. This had resulted in 
moving the social work service out of the building and into a container in close proximity 
to the unit. Though the waiting area in Site A was often overcrowded, there was a second 
waiting area to which patients requiring any laboratory tests were referred. Health 
information notices and prayers are displayed on an information board in the smaller 
waiting area. While there was some movement of patients between waiting areas, the 
main area where patients collect their files remained busy. During exit interviews, patients 
were asked how many hours they spent at the clinic at each visit. In Site A, the length 
varied from one to twelve hours. The greatest number of patients spent five hours at the 
clinic at each visit (42/187 or 22%). In comparison, the time spent by patients in Site B 
ranged from one to eight hours. The majority of patients interviewed (48/159 or 30%) 
spent four hours at the clinic for each visit. This considerable difference may be 
attributed to the number of patients receiving treatment at each site. In Site B, some 
building work had been done to create the new ART clinic. Despite this, there was no 
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allocated waiting area and patients sat on benches in the passage behind a closed door. 
As the number of patients on treatment increases, it is likely this will become increasingly 
problematic.  
 
3.5.2 Drug distribution and supply 
CCMT Managers in both sites reported that they had not experienced many problems 
with drug stock outs in the last six months. Pharmacies in both sites were visited to 
confirm the availability of drugs listed in Table 14 below. All these drugs form part of the 
Essential Drug List. 
 
Table 14: Checklist of drugs and supplies 
General drugs and supplies Anti-Retrovirals 
Sharps disposal containers Stavudine caps 30mg (Stavir/d4T) 
Condoms Stavudine caps 40mg (Stavir/d4T) 
Ciprofloxacin tablets Stavudine solution1mg/ml (Stavir/d4T) 
Flagyl (Metronidazole) 400mg Lamivudine tabs 150mg (3TC) 
Erythromycin 250mg tabs Lamivudine solution 10mg (3TC) 
Doxycycline 100mg tabs Efavirenz caps 200mg (Stocrin /EFV) 
Latex gloves Efavirenz caps 50mg (Stocrin /EFV) 
Rapid HIV/AIDS testing kits Efavirenz tabs 600mg (Stocrin /EFV) 
Purple topped blood specimen 
containers 
Didanosine tabs 200mg (Videx/ddI) 
Nevirapine tablets 200mg Didanosine tabs 100mg (Videx/ddI) 
Nevirapine suspension 50mg/5ml Didanosine tabs 50mg (Videx/ddI) 
Nystatin Zidovudine tabs 300mg (Retrovir/AZT) 
Analgesia (paracetamol) Zidovudine syrup 50mg/5ml (Retrovir/AZT) 
Cotrimoxazole (Bactrim) syrup Lopinavir/Ritonavir caps 133/33mg (Kaletra) 
Cotrimoxazole (Bactrim) tablets Lopinavir/Ritonavir suspension 80/20mg/ml (Kaletra) 
Acyclovir 800mg Ritonavir suspension 80mg/ml (Norvir) 
Amitryptaline Ritonavir caps 100mg (Norvir) 
Hydrocortisone cream Abacavir tabs 300mg 
Loperamide 2mg Abacavir solution 20mg/ml 
Sputum containers  
 
At Site A, the chief facility pharmacist was responsible for the ordering, control and 
receiving of all drugs. The drugs were kept at the main pharmacy and fetched by the 
ART service as needed. The Facility Manager at the site indicated that the facility almost 
never ran out of essential drugs and that the facility was able to order drugs daily when 
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the availability of specific drugs was declining. The CCMT Manager indicated that the 
relationship with staff in the wards was good, and that staff did phone when patients 
who were on treatment ran out of drugs while admitted. This was quite different to the 
initial concerns raised by the CCMT Manager that communication between the wards 
and the ART clinic was erratic due to lack of staff, leaving full responsibility for follow-
up of patients with the CCMT Manager directly.  
 
The drug supply at Site B was managed by professional nurses. The Facility Manager in 
the site also indicated that the facility almost never ran out of essential drugs. The central 
distribution depot informed the Site when it was out of stock of certain items and would 
deliver such drugs as soon as they arrived at the central depot. ART drugs were kept in a 
separate store room at Site B. Though both sites had a dedicated pharmacist, it was only 
in Site A that the dedicated pharmacist manages the ART drugs. In Site B, ART drugs 
were managed by the CCMT Manager. Tracking of defaulters was done by the 
pharmacists in both sites. 
 
Table 15: Drugs and supplies not in ARV pharmacy 
Drug name Facility Reason 
Videx 200mg Site A Not given (2nd line regimen drug) 
Videx 50,100, 200mg Site B As 2nd line regimen drug, not routinely 
stocked. Only seeing patients being put on 
2nd line regimen drugs recently, on order at 
time of visit 
Rapid HIV Testing Kits Site A In consulting rooms 
Rapid HIV Testing Kits Site B In consulting rooms 
Nevirapine tablets 200mg Site A In labour ward 
Nevirapine suspension 50mg/5ml Site A In labour ward 
Ritonavir suspension 80mg/ml 
(Norvir) 
Site A & 
Site B 
Not given 
Ritonavir caps 100mg (Norvir) Site A Not given 
 
The CCMT Manager in Site A reported a shortage of Stavudine (paediatric formulation) 
during July and parts of August 2006. This was managed by providing patients with a one 
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week supply. In a very small number of patients, patients missed treatment for two 
weeks. It was acknowledged that this was a risk for adherence.  
 
3.5.3 Laboratory capacity 
Both Sites A and B reported that they did not have major problems with the laboratory 
service and the turn around time for results. Turn around time ranged from 48 hours to 
five days. The information provided by the Facility Manager and the CCMT Manager as 
to the availability of tests and the turnaround time was not consistent in Site A. 
Budgetary issues in Site A meant that CD4 counts could not be requested or conducted 
in the Outpatient Department and had to be conducted within the CCMT service. In 
certain exceptions, doctors were able to request CD4 counts for in-patients to be done 
directly. The Facility Manager reported that the relationship with the laboratory service 
was good and that the service was reliable. Where results were not returned to the facility 
or were needed urgently, staff were able to call the service directly for results.  
 
Tests for Viral load, Liver Enzymes, HIV ELISA tests and PCR all had a five day 
turnaround time in Site B. All major tests were available on site.  Staff were able to call 
the laboratory directly in instances where results were not immediately available. As in 
Site A, the laboratory service was able to provide results telephonically, informed staff 
when the results were needed urgently and that the facility needed to trace the patient as 
soon as possible. Specimens were collected from Site B daily by a courier and results 
returned in the same way.  
 
3.5.4 Use of staffing guidelines and protocols 
CCMT Managers were asked what protocols were used in the CCMT service and asked 
to indicate where such protocols were displayed. Most of the protocols were immediately 
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available and used by staff working in the CCMT service. In certain instances, protocols 
were located in other HIV related services. For example, protocols relating to infant 
feeding and PMTCT, and management of HIV positive pregnant women were kept in 
the ANC section in Site A. Protocols relating to the Management of a person with a STI 
and National Guidelines on home-based care and community based-care were not 
available within Site A. It is possible that guidelines for the management of STIs were 
located in the outpatient section (not immediately observable). All the protocols listed 
were immediately available within the same building in Site B. This is because all HIV-
related services were within the same building.  
 
3.6 Clinical information systems 
 
In both sites, patient files were kept in a lockable cabinet. Both sites had rooms in which 
data capturers and clerks worked. Laboratory data was recorded on computers in these 
rooms. In Site A, a counsellor was able to provide data pertaining to the full outpatient 
services, but some routine data elements were not easily available. Data capturers were 
able to provide routine data in Site B that the Facility Manager did not have in her office.  
 
Table 16: Reporting processes in place at Sites A and B  
Sit
e 
Dept Content To Frequency Paper or 
electronic 
Local, 
provincial 
or national 
design 
 Number visiting VCT 
service, number of 
discordant partners, 
number testing HIV+, 
number referred to 
ART clinic 
CCMT 
Manager 
Monthly Paper Own 
ART Pharma-covigilance  Medunsa Quarterly Electronic Own 
A 
ART Numbers on treatment, 
number of CD4 counts 
and viral loads 
conducted 
Province Monthly Electronic Province 
  67 
VCT Number of HIV tests 
done, number of HIV+ 
results, CD4 counts 
done, staging, age of 
patients 
Regional Monthly Paper Own 
CCMT Headcount, number of 
repeat scripts filled, 
referrals 
District Monthly Electronic Province 
CCMT Number of new 
patients initiated o 
treatment, Numbers on 
treatment, number of 
CD4 counts and viral 
loads conducted, 
number of deaths, 
drop outs and 
transfers 
District Monthly Electronic Province 
VCT Number visiting VCT 
service, number of 
discordant partners, 
number testing HIV+, 
number referred to 
ART unit 
CCMT 
Manager 
Monthly Paper Province 
B 
PMTCT Referrals received, 
number of CD4 counts 
and viral loads taken 
CCMT 
Manager 
Monthly Paper Own 
 
3.6.1 Data collection and storage 
Facility and CCMT Managers were asked to provide information about the collection and 
recording of statistics within HIV-related services. The Facility Manager at Site A 
indicated that the facility receives very little support from the Region and that the only 
time they see anyone from the Region is when they want statistics.  
 
When requesting copies of routine data at Site A, the data available was manually 
recorded and located in the office of the CCMT Manager. It was not possible to draw the 
data from the computer located in her office. Information systems and data collection 
processes in Site B were well managed. The Facility Manager had a very good 
understanding of the various data elements and was able to speak to the data and 
possible causes for changes in the number of patients using the service and any variations 
in head counts. Though the data management system appeared better in Site B, only 67% 
of patients had viral load results available in their files, as compared to 83% at Site A. 
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CHAPTER FOUR – DISCUSSION 
  
The previous chapter has provided a summary of the main findings generated from key 
informant interviews, SAQs and observations completed in Sites A and B. This chapter 
will provide a discussion on levels of adherence and organisational capacity within both 
sites using Wagner’s Chronic Care Model as the framework for analysis. Elements of the 
Chronic Care Model that will be discussed are prepared proactive practice teams, delivery 
Systems design, decision support and clinical information systems. 
 
Both sites appeared to be functioning relatively well. Areas of difficulty were not 
dissimilar to those facing the CCMT programme more broadly. Each had strengths in 
different areas and displayed efforts to manage constraints. Staffing at both sites was 
relatively stable, though levels of motivation varied. The use of data to inform decision-
making and assess overall performance differed between sites. The Facility Manager in 
Site B had a stronger grasp of CCMT data. It is important to note that the Facility 
Manager in Site A was responsible for the Outpatient Department (working across a 
much bigger service) and was not as close to the CCMT service. Despite these 
differences, adherence was fairly similar in both sites. 
4.1 Prepared proactive practice teams 
 
4.1.1 Staffing  
There was a general view that a major deficit in the current staffing situation is the 
shortage of nurses and pharmacists. The lack of pharmacists was an issue that was raised 
by the Facility Manager, CCMT Manager and the TB nurse during interviews at Site A.  
Significant staffing gaps included the shortage of nutritionists and social workers. The 
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tasks and responsibilities of these three professions are crucial to initiating and 
maintaining patients on treatment. At the same time, the proposed staffing guidelines 
presented in Table 6 need to be reconsidered. In certain instances, as programmes 
mature and patients remain stable on treatment, the responsibilities and tasks of 
professionals may shift.  
 
This will involve reconsidering the staffing ratios in line with available skills and 
knowledge among stable patients, community members and other organisations involved 
in the ART rollout. In Site A, it was very clear that the ability of the site to continue 
initiating patients on treatment and to address the backlog of patients waiting to start 
treatment would require the reorganisation of tasks or an increase in the number of staff 
working within the CCMT service. While the staffing formula outlined in the CCMT 
Plan would suggest that there are staff shortages in Site B, the site appeared to be able to 
meet current patient needs. Treatment initiation rates appeared to be relatively constant 
and there is no waiting list. Site B also has an enrolled nursing assistant working within 
the CCMT service. There were no enrolled nursing assistants working in the CCMT 
service in Site A.  
 
Shortages of professional nurses and other scarce skills professionals have been 
described elsewhere as one of the major barriers for the expansion of South Africa’s 
ART programme. The CCMT Plan proposes increasing the recruitment of nurses for 
training; creating new posts; and creating new categories of health workers. To date, no 
substantial increase in the number of nursing graduates has been noted. Secondly, nurses 
who are currently studying do not receive any specific training in HIV or the 
administration of ART. This is a major shortfall in light of the escalating AIDS crisis 
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 Task shifting and the creation of new categories of health workers needs to be seriously 
considered as a solution to human resource constraints. This would ensure that capacity 
is built internally, the health system is strengthened and available human resources are 
utilised optimally. Careful consideration will need to be given to identifying tasks that can 
be shifted to lower category health workers. One example where this is the necessary is 
the use of pharmacy assistants to dispense treatment for patients collecting repeat scripts 
of medication. The shortage of medical officers has resulted in the emergence of nurse-
centred CCMT Programmes and was identified as a major strength of both programmes 
included in this study. However, for Site A to continue to expand and maintain high 
levels of adherence, task shifting is imperative.  
 
4.1.2 Productive patient-provider interactions 
Both sites demonstrated varying levels of interaction and relationships between patients 
and staff. Observations by the researcher provided a somewhat different picture to the 
input shared during in-depth interviews with staff and patient exit interviews. 
Observations at Site A suggested the presence of good and positive relationships 
between patients and health care workers, suggesting high levels of acceptability1 among 
patients, one of the basic criteria for assessing levels of access to the ART service. This 
was borne out by low staff turnover and positive interaction between staff and patients in 
the waiting area of the ART clinic. Stability in staff within the CCMT service was likely to 
mean that patients have developed relationships with staff members who had a solid 
knowledge of patient’s own individual circumstances and factors which may affect 
adherence to treatment. This was also supported by reports and observations that 
                                                
1
 Acceptability is the extent to which patient expectations are met. High levels of acceptability indicate 
that patients are generally satisfied with the health care provided.  
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patients travelled beyond the reach of Site A to be cared for by nursing staff who were 
previously working within the HIV/AIDS sector at a different public sector facility in 
Gauteng.  
 
This is in contrast to Site B where there had been three CCMT Managers since the 
programme was initiated in 2004. Observations noted health workers interacting very 
little with patients and the shortage of professional nurses in the unit meant that patient 
consultations were very brief. The outgoing CCMT Manager reported that staff turnover 
was making it difficult to establish and maintain relationships between health workers 
and patients. 
 
The quality of patient-provider relationships within both sites may also have been 
influenced by the quality of relationships among staff. Staff who feel motivated and 
committed are more likely to work well in a team and to work towards achieving 
common goals. Both observations and responses by staff in Site A suggested higher 
levels of organisational loyalty and team work, although this did not appear to affect 
outcomes in any significant manner.  
 
4.2 Delivery systems design 
 
4.2.1 Access to Services  
The accessibility of both sites to patients was seemingly influenced by the geographical 
location of the site, the costs associated with attending the ART clinic and the experience 
and interactions of patients with health workers. Both sites exhibit varying levels of 
access. Both are accessible to patients for different reasons. The previous section 
provided considerable detail regarding the quality of human interaction within both sites. 
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While Site A may display good quality human relationships, it was more expensive to 
access and the geographic proximity to the target population varied considerably. Despite 
the barriers imposed by cost and distance, enrolment remained high in Site A.  It is 
important to reflect on whether the absence of a waiting list and the slower uptake of 
ART at Site B were reflective of the patient experience of human interactions or the 
lower level of need in the surrounding area.  
 
The delay in rolling out a second ART site within the catchment area of Site A placed 
considerable pressure upon the existing ART service. Patients came from a large 
geographical area, making it especially difficult to create and maintain strong community 
relationships with multiple stakeholders. This may also have possibly caused difficulties 
with the ongoing follow-up of patients at community level. Secondly, the material costs 
(R25 per visit) associated with attending the CCMT site at Site A were considerably 
higher than Site B (R16 per visit). In instances where levels of employment were low, 
high costs may prevent patients from keeping their appointments. There is a risk that 
patients who are stable and have achieved viral load suppression may perceive 
maintaining adherence to treatment as being of lesser importance than if the patient was 
AIDS sick. In contrast, the costs were less at Site B but overall levels of utilisation were 
lower.  
 
4.2.2 Pathways of care 
The efficacy of monitoring and follow-up is influenced by the extent to which health care 
providers, units and facilities work well together. This is commonly referred to as the 
integration of services or pathways of care. Integration of services and cooperation 
among health care providers to ensure adherence needs to take place at internal and 
external levels.  
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The CCMT Plan places significant emphasis upon the interface between health care 
professionals and multiple service delivery points interacting with patients who are 
registered with the CCMT Programme. These include, but are not limited to, 
reproductive health care services, primary health care clinics, and TB, VCT and inpatient 
services. While each site was able to explain the referral of patients between services, this 
was not always working smoothly. This is exacerbated by capacity deficits at a human 
resource level. In certain instances, this has resulted in the vertical implementation of key 
programmes.  
 
The shortage of staff and the lack of space in Site A resulted in a situation where TB 
services, wellness activities and NGO support are all located outside of the CCMT 
service. This creates potential for the large fall-out of HIV positive patients from the 
CCMT Service. This is of particular concern among patients who are taking TB 
treatment or participating in wellness programmes at community level. 
 
 Once patients leave the CCMT service, it becomes much harder to track their health 
status, assess when treatment preparation should begin and when additional support is 
required. It also places the burden on the patient to return for care when the individual 
deems it necessary. In many instances, this is often when the clinical prognosis is poor 
and successful clinical outcomes are less likely. The fall out of patients from Site A, even 
if not quantified, was likely to be significant. It points to the division of responsibility 
between Primary Health Care services provided by local government and secondary 
services provided by the provincial Department of Health. This disjuncture created the 
potential for patients to get lost in the system with no means for follow up.  
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When patients remain in the same service, it is easier to ensure that health care needs are 
being appropriately responded to through ongoing monitoring. The split between 
hospital and clinic-based care is further exacerbated by the fact that patients need to be 
referred from clinics back to ART sites for their CD4 count and viral load, creating 
further time delays and affecting the seamless movement of patients between services. 
 
There is a dual imperative to ensuring high levels of adherence to ART. There is the 
concern for the individual wellbeing of patients with HIV, as well as the broader public 
health gains to be realised when patients are able to access treatment and manage their 
HIV status in a way that reduces the spread of HIV and prolongs life. Keeping patients 
in the same service will respond to both imperatives, and will remove the obligation to 
pursue broader public health gains from the individual patient.  
 
4.2.3 Role of NGOs and community organisations working with lay workers 
Two categories of NGOs exist that have been influential in the roll-out of ART across 
South Africa. The first are NGOs with medical expertise that have championed the roll-
out in first generation sites and have pioneered models of care for resource-poor settings. 
The second category includes organisations providing general welfare services, 
counselling and family support through lay workers, some of which are based in CCMT 
sites across the country. This study focussed specifically on the second category of 
NGOs. The arrangements pertaining to the training and deployment of lay counsellors 
and volunteers to CCMT sites created complexities in management and accountability. 
Both staff and lay counsellors raised concerns relating to this arrangement. These areas 
of difficulty were not dissimilar to the divided responsibilities and tasks between local 
government and the provincial Department of Health. The division of responsibility and 
accountability created a considerable barrier to ensuring seamless movement between 
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services and effective cooperation between the CCMT service and organisations. In 
response to the shortage of staff in scarce skills areas, both sites utilised task shifting, 
through the use of lay counsellors and volunteers across services to perform core support 
tasks. These tasks pertained to assistance in the pharmacy, conduct of adherence 
assessments once treatment preparation had been completed, and the provision of 
nutritional guidance to patients. Until reporting lines and management structures are 
merged, the potential to abdicate tasks and responsibilities will pose a serious threat to 
the delivery of comprehensive high quality care. 
 
The lack of consistency in, and information on, the content of training provided to lay 
counsellors made it difficult to accurately assess levels of competence. The division of 
management responsibilities across multiple NGOs can also lead to large discrepancies in 
the quality of supervision and oversight provided to those working in public sector 
facilities. This is of concern when considering the multiple roles and areas of 
involvement of lay counsellors and volunteers. For example, counsellors in Site B moved 
between the ANC section, the VCT section, drug literacy and the ART service. 
 
The absence of formal commitments and arrangements between many CBOs and NGOs 
who were providing services to patients within the CCMT service can compromise 
adherence due to the interruption of services as a result of funding delays and the 
absence of enforceable, specific contractual arrangements for service provision within 
CCMT sites. Ad hoc arrangements with NGOs make it difficult to implement and 
maintain basic standards for service delivery. Ongoing NGO involvement appeared in 
both sites to be based on organisations coming forward and offering services of their 
own initiative. Where contracts exist with the Departments of Health and/or Social 
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Development, there were accountability measures, but these often did not relate 
specifically to tasks and responsibilities within the CCMT service. 
 
The 2007- 2011 National Strategic Plan speaks to the need to create career path 
programmes for various cadres of counsellors and volunteers working in the health care 
system (South African Department of Health, 2007a). Lay counsellors working in the 
VCT service at Site B echoed this request and the wish to have their qualifications and 
training recognised as complying with official unit standards. The Strategic Plan suggests 
that this process has begun. For it to be most beneficial, the programme needs to be 
expanded and accessible for such cadres of health workers. 
 
4.3 Decision support  
 
4.3.1 Physical infrastructure 
In both sites, the allocated space for the ART service was not ideal. In particular, the 
waiting area could not accommodate all patients waiting to be seen. This was a greater 
problem in Site A due to the higher number of patients attending the clinic each day, and 
the congestion was seen as a consequence of the rapid growth of the programme. 
Without task  substitution, decentralising treatment access or a significant injection of 
staff, it is likely that waiting lists will continue to increase and the quality of care provided 
to patients will decline. There were noticeable disparities in space in Site A. For example, 
the ANC service situated opposite the ART clinic was significantly larger in size with a 
far bigger waiting area. 
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As ART sites expand, physical infrastructure will become a problem. The shortage of 
space in both sites was already an issue. While both units were located in a separate area 
and not in full view of other services, the size of the waiting areas in both sites was a 
problem. 
 
4.3.2 Drug distribution and supply 
Problems with drug supply and distribution are not uncommon in ART sites and have 
been reported in treatment programmes in South Africa. However, neither sites in this 
study had any major problems with drug distribution and supply. Site A had experienced 
a temporary shortage of paediatric Stavudine, but had overcome the problem by 
dispensing a smaller dose and requesting the patient to return a week later. No patient 
had ever been sent away without any medication. Drugs that were not available in Site B 
were second line regimen drugs that were not on prescription for any patient as yet. 
Barriers to access existed in there being only one pharmacist in Site A and only a part-
time pharmacist who was going on maternity leave in Site B. There are possibilities for 
task shifting to address this. The sites had put in place contingency measures to address 
drug shortages. It is unclear how Site B managed the dispensing of drugs with only a 
part-time pharmacist. 
 
Pharmacists and dieticians are recognised as part of the scarce skills category of 
professional staff. Without addressing this gap through task shifting, there is a possibility 
that the number of patients defaulting on treatment will increase. This is also likely to 
increase the risk of viral resistance. Ways to address this risk need to be explored further. 
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4.3.3 Laboratory Capacity 
Neither site had experienced any difficulty in obtaining laboratory results. The disparity 
in the number of patients who were interviewed with viral load results available in their 
files (83% in Site A and 67% in Site B) raises some cause for concern, however, it was 
not clear whether this points to gaps in record-keeping or the tests not having been 
performed. If it is the latter, this also needs to be addressed. The one barrier which 
existed in the execution of laboratory testing was budgetary allocations for specific tests. 
Ring-fenced funding for ART placed the cost of performing CD4 counts in the CCMT 
service at Site A. Patients who were identified or admitted needed to be referred to the 
clinic for such tests. The presence of a waiting list in Site A may have introduced delays. 
3.4.2 Relationships with districts and the region 
Though there were generally good relationships among staff within both facilities, the 
sites experienced some distance in their relationships with the district and the region. 
There was very little feedback provided on data submitted. This feeling of a lack of 
support may have contributed to the isolation felt by staff at facility level. Staff in Site A 
also reported that there had been too many changes at the facility in the last six months. 
4.4 Clinical information systems 
 
4.4.1 Data collection and management 
Routine data provides an important means of evaluating site performance, identifying 
health needs and assessing trends in service delivery within CCMT sites. In both sites, the 
responsibility for collecting and collating data was shared among different staff 
categories.  
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Data collection processes and the use of data to inform practice varied considerably 
between sites. In Site A, there were gaps in TB statistics as it appeared that patients were 
being tested and treated for TB within the hospital and that this information was not 
being passed on to the TB Focal Point. This resulted in an under-representation of the 
number of patients diagnosed with TB and the number started on treatment.  
 
The process of referring patients to NGOs for ongoing treatment support also affected 
the reliability of data reported. The relationship with NGOs involved in monitoring TB 
and HIV patients at Site A was informal. There was no indication that community 
organisations were submitting data to the site. When looking at the referral process 
within the ART service, data for drop-outs and defaulters was not reliable as the process 
of monitoring patients relied heavily on NGOs and information was not provided to the 
site on a specified, regular basis. The absence of reliable data made it difficult to establish 
the nature of problems within sites and to identify priority clinical outcomes that require 
urgent attention. The disjuncture between the process of data collection and collation 
also meant that staff were somewhat distanced from the data once it had been collated at 
a higher level.  The input and use of data in Site A required further attention. Many of 
these inaccuracies and gaps in data had arisen as CCMT staff were over-stretched.  
 
There appeared to be congruence between sites regarding the data items being collected 
and reported. It was clear that sites were following a template required at regional and 
provincial level. However, there was inconsistency in the definitions being applied 
regarding the categorization of patients as having defaulted, dropped out or transferred 
out of the programme. Though these three data items all provide valuable information 
regarding retention, the inability to distinguish between these definitions made it difficult 
to track areas of movement and gaps within the programme. If more detailed 
  80 
information was available, it would be easier to monitor trends in the evolution of the 
treatment programme.  
 
In both sites, the data is often not used and interpreted by those who collect it directly2. 
Effective data collation and monitoring of the CCMT programme is also hampered by 
the lack of a central authority for submission of data by researchers (Kahn, 2008). 
                                                
2
 Data is often collected and collated by administrative clerks who do not play an active role in the 
CCMT service. 
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CHAPTER FIVE – RECOMMENDATIONS 
 
 
This final chapter seeks to provide recommendations for intervention based on the 
findings of interviews with staff, SAQs and patient exit interviews. The two sites 
demonstrated similarities and differences in functioning when reviewed using Wagner’s 
Chronic Care Model. This chapter will break down and propose recommendations in line 
with each element of the CCM.  
 
5.1 Prepared proactive practice teams 
 
5.1.1 Staffing allocation and task descriptions 
When comparing the number and skill level of staff within each site against the Strategic 
Plan, it appeared that gaps in staffing and skills exist in both sites. These gaps had 
implications for quality of care. While increased staffing needs to be considered, it would 
be unrealistic to recommend further increases according to the proposed norms outlined 
in the CCMT Plan.  
 
In certain categories, such as pharmacists, recruitment “ceilings” had already been 
reached. It may thus have been more feasible to revisit the task description for each 
category of health worker and to consider increased training and deployment of mid-level 
categories. Again using the example of pharmacists, as the programme progresses and the 
number of patients requiring treatment continues to increase, it is anticipated that 
patients with poor adherence will need to move to second-line regimen drugs. Additional 
support and tasks will be involved in the management of patients who require second-
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line regimen drugs. It is expected that these patients would require further attention and 
assistance to ensure that any concerns related to side-effects are suitably dealt with by the 
pharmacist. This is nearly impossible when pharmacists are faced with such a high 
number of patients to be seen each day. Though the CCMT Plan has not assumed any 
decline in patient-provider contact time, the staffing needs remain under-estimated. The 
presence of trained pharmacy assistants could alleviate some of the pressure placed upon 
pharmacists by delegating tasks to be completed. 
  
With sufficient structure and formalisation of relationships with NGOs, it is possible that 
specific basic tasks could be absorbed by NGOs and Community-Based Organisations 
(CBOs). An example of this is the use of social auxiliary workers and community 
development workers to do follow-up visits with patients who have not returned for 
treatment. Social auxiliary workers are able to work under the supervision of a social 
worker and, with sufficient guidance, can take over some responsibility for assessing the 
social circumstances of patients. This can form part of task shifting and substitution in 
order to cope with high patient numbers and increasing need. 
 
5.1.2 Training and skills development 
Training and skills development among staff working within the CCMT service should 
be made a priority when implementing interventions to improve CCMT services. This 
relates to training in HIV, ART and the management of TB-HIV co-infection. This is in 
line with the recommendations in the National Strategic Plan. There is a need to 
harmonise training offered to lay counsellors to ensure a common basis of training and 
understanding. This process should be done in collaboration with the relevant Sector 
Education and Training Authority (SETA). This was articulated by counsellors in both 
sites. 
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5.1.3 Workload and burn out 
The nature of work within the CCMT service is emotionally demanding and can 
negatively affect motivation and quality of care provided to patients. The need for regular 
debriefing by credible, preferably independent, agencies can not be over-emphasised. 
This should form part of the budget for each site and not be based on the ad-hoc 
possibility of funding being available. The lack of emotional support may form one of 
the reasons that nurses are leaving the public sector. Good internal relationships between 
colleagues provide some emotional support but are not an adequate response to the 
needs expressed by staff. Nurses and doctors who head the services also experience 
emotional burnout. Implementing support structures through a formal contractual 
arrangement could assist in ensuring the long-term sustainability of this initiative. 
 
5.2  Delivery systems design 
 
5.2.1 Integration of services and continuity of care 
This report has highlighted the importance of ensuring that there is continuity of care as 
patients move between services and ensuring that patients remain within the same 
facility. This ensures that patients are monitored on an ongoing basis and decisions about 
treatment can be made sooner. The creation of well-functioning Wellness Programmes is 
vital to ensuring this continuity of care. This is afforded priority in the National Strategic 
Plan. The delay in starting patients on treatment due to lack of capacity means that it is 
imperative that emphasis is placed upon patients maintaining good health as far as 
possible. 
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 The process through which patients are managed within facilities requires consideration. 
The continued absorption of patients in hospital sites without down-referral to clinic 
level will continue to place increasing pressure upon existing sites. This is not sustainable 
and will compromise the quality of care available to patients. There is a need to accelerate 
the roll out, and accredit PHC clinics to initiate and maintain patients on ART. 
Historically, primary health care clinics are greater in number and are closer to 
communities. The high cost incurred by patients to attend the CCMT service in both 
sites highlights the need to prioritize and accelerate the preparation of PHC clinics for 
the rollout of ART and support. This will ensure that facilities can continue to absorb 
patients, and patients who have completed treatment preparation can begin treatment 
sooner. Decentralising treatment access is also likely to reduce the cost of accessing 
treatment for patients.  
 
5.2.2 Managing TB/HIV co-infection 
Another important component to ensuring the effective management of people with 
HIV/AIDS prior to starting treatment is the effective management of patients who are 
co-infected with TB. TB and HIV are two epidemics that have grave public health 
implications if they are not managed appropriately. The entry of patients into the ART 
service provides a valuable opportunity for simultaneous intervention. Taking TB 
treatment and ART simultaneously can be complex. Both can have severe side-effects 
and it requires taking a high number of tablets each day. This may compromise 
adherence among patients. While there has been a commitment to starting patients on 
TB treatment prior to beginning ART, there appears to be insufficient monitoring of 
patients within each programme. This is further exacerbated in Site A where the 
management of patients taking TB treatment happens at clinic level. Similarly, the 
protocol for encouraging TB testing for every patient with HIV needs to be afforded 
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greater priority. This is only likely to be effective where there are clear processes for the 
movement of patients between TB and ART services, and where ongoing monitoring is 
taking place. This requires strengthening and formalising relationships with NGOs at 
community level. 
 
5.2.3 Role of NGOs and community organisations 
The gaps in capacity within existing ART sites and the delay in accrediting ART sites in 
various areas confirms the need to strengthen service co-ordination between sites and 
communities. This could be done through formalising relationships with existing NGOs 
providing similar services at community level. This would also capitalise on existing skills 
and community resources. For example, NGOs providing DOTS support have 
experience in supporting patients taking chronic medication and are likely to have 
knowledge of issues affecting adherence to chronic medication. By centralizing and 
formalising relationships with NGOs, it will be easier to manage external service-
providers and to ensure accountability by service providers. 
 
The disjuncture between the employer, lines of accountability and the site in which lay 
counsellors are based has created difficulties in the delivery of ongoing high quality care. 
The absence of standardised training and the lack of clear roles and responsibilities has 
made it difficult to hold lay counsellors to account for their conduct. Roles and 
responsibilities differ across sites and CCMT sites are not always clear on the contents of 
job descriptions prepared by NGOs. Specific task descriptions need to be developed and 
managed by CCMT sites. This will ensure that CCMT sites can oversee the work of 
counsellors and take remedial action where necessary. 
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There is a need to review the current process of funding NGOs to deploy counsellors to 
health care facilities. It would seem that it may be more appropriate to fund NGOs to 
train counsellors in a SETA accredited course or programme, but that counsellors are 
contracted and employed by the site in which they work. If this is not feasible, 
counsellors working within the CCMT service should be affiliated to an NGO that has 
an ongoing established presence at CCMT sites. The gaps in staffing mean that 
counsellors have a valuable role to play in supporting treatment preparation, conducting 
follow-up visits, pill counts and providing psycho-social support. For this to be effective 
and sustainable there is a need to ensure continuity and ongoing service delivery. This 
relies upon there being clear reporting lines, management and accountability between 
CCMT Managers and lay counsellors. 
 
5.3 Decision Support 
 
The lack of the support from the Region that is felt by staff working in the ART service 
needs to be addressed urgently. Though support structures and reporting lines are 
relatively clear within each site, the absence of support and feedback from the Region is 
of concern. With more effective communication and support, it is likely that staff would 
feel less isolated in coping with a heavy workload and emotional stress.  
 
The lack of training in key areas may also influence the application of protocols and 
guidelines. Improved training and greater coverage of staff in the service is likely to 
improve the use of guidelines and protocols. It is important to record that this was not 
identified as a weak point during the study, but it is likely there is scope for improvement. 
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5.4 Clinical information systems 
 
5.4.1  Monitoring & Evaluation processes 
The lack of consistency in the application of indicators when collecting routine data has 
severe implications for the validity of data items collected within sites. It appears that 
sites are not monitoring the number of patients who have fallen out of the ART 
programme. This is observed in the lack of differentiation between transfer and loss to 
follow up. The lack of clarity on the application of such indicators may point to the need 
for further training and, or, the need for clerical staff to understand the importance of 
collecting valid data. 
 
It appeared that death data was not always reported to ART sites due to the lack of 
volunteers affiliated to community organisations and working in cooperation with CCMT 
sites. Instances were reported where patients had died but the facility did not know, and 
the patient was recorded as lost to follow up. This indicator tends to become an all-
encompassing category used to record any data pertaining to patients who have not 
returned to the site. While this provides a crude analysis of site-level functioning, it is 
imperative that this is disaggregated accurately and distinguishes between deaths, 
transfers out and patients who are lost to follow-up. 
 
5.4.2 Data collection and reporting processes 
The second area of concern relating to clinical information systems is the process by 
which data is collected and reported. It is unclear how data is recorded or adjusted where 
a patient has not arrived for their appointment on an allocated day, but does attend the 
clinic on a different day. Where data is collected and recorded daily, the number of 
patients who have missed appointments is recorded on a daily basis. It is not clear if or 
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how this data is adjusted for patients who arrived on another day and are not lost to 
follow up. 
 
The process of data collection relating to the TB and ART services in sites where high 
numbers of patients are taking TB treatment and ART simultaneously must be afforded 
priority in improving adherence among patients taking ART. This highlights the 
importance of ensuring that data is interpreted and made available to sites. The process 
of monitoring and evaluating treatment programmes needs to be seen as a priority focus 
area, and not merely as a last end activity that is of lesser importance to other staff duties. 
For as long as this message comes from a regional level, it will continue to be perceived 
as an instruction that brings more work, with no understanding of the value of accurate 
data and the important role it can play in improving quality of care provided to patients, 
with subsequent gains in increasing levels of adherence among patients taking ART.  
 
If not enough emphasis is placed upon the importance of collecting accurate data, it will 
be difficult to thoroughly evaluate and assess the overall functioning of the CCMT 
programme nationally. As the number of patients who are co-infected with TB and HIV 
continues to increase, there needs to be greater collaboration and ongoing monitoring in 
place between sites. This is of great importance when the division of responsibilities 
remains split between local and provincial government. It is also possible that patients 
who are defaulting on TB treatment may also be defaulting on ART and vice versa. One 
consistent community-based monitoring mechanism and the management of patients at 
PHC level could address these two concerns simultaneously. 
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University of Witwatersrand 
School of Public Health 
Faculty of Health Sciences 
___________________________________________________________________________________ 
Information Sheet – Facility Manager 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng Province 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have cooperated on a number of HIV/AIDS projects in recent years. The theme of the current 
research project is adherence to Anti Retrovirals. Specifically, we are tasked with investigating the facility 
factors (for instance, presence of lay counsellors) that promote adherence in patients, which we refer to as 
“organisational capacity”. Another team of students will be doing research on the patient side of 
adherence. Once completed, the two studies will be combined in one report for Gauteng Province in 
which we hope to make recommendations for the strengthening adherence in treatment sites. We would be 
most grateful if you could help in this research by providing information on these factors that relate to Anti 
Retroviral adherence in patients.  
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that 
were randomly selected for the project. As the manager of the facility we would like to interview you. The 
purpose of the interview with you is to obtain a general understanding of the facility in which the ARV site 
is located, such as the staff and resources in the facility as a whole, and how you see the link between the 
ARV programme and the rest of the facility.   
 
What can I expect and what will be expected of me? 
One of us will interview you and take notes using a semi-structured questionnaire. We will also ask your 
assistance in gathering information on aspects such as staffing, drug supplies and facility statistics. The 
interview will take about one hour or so to complete. Your views will be combined with those of other 
Facility Managers and neither your name nor that of the facility will feature in the report.   
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the interview or any additional 
information obtained from registers and routine data will only be known to the researcher. This 
information will not reflect peoples names or patient numbers and will only show case numbers via a 
coding system. By participating you will help us understand the challenges facing managers in 
implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
All information that is obtained in this study will be kept confidential. Please note that to ensure that this is 
maintained, interview schedules will be coded and will only indicate the date of the interview and the 
facility code. Your participation will remain anonymous. Information pertaining to interview schedules will 
be kept in a separate file from the rest of the report, under lock and key in a safe place by the researcher. 
 
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo Tel: 082 490 1214  Email: nickynaidoo@gmail.com 
Rebecca Pursell Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
 
Our supervisor is Professor Helen Schneider and she is contactable on: Tel: 011-242 9905   Email: 
helen.schneider@nhls.ac.za 
Sincerely,  Nicolette Prea Naidoo  Rebecca Pursell 
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Consent Form for Facility Manager 
 Organisational capacity affecting patient adherence to ARVs in Gauteng 
Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate?
 Yes/No 
 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes 
 
Do you agree to be interviewed for the project  Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo    Rebecca Pursell 
Tel: 082 490 1214   Tel: 082 828 7387 
Email: nickynaidoo@gmail.com   Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
  
Facility Manager Interview Schedule 
 
Interview details        
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: ________________  
1.4 Facility code: _____________ 
1.5 Data capturing:  Date:   By:  
________________________________________________________________________ 
2. Clinic profile and staffing 
2.1  Could you tell me what services are provided at this outpatients department/clinic?  
 
(Fill in the table and prompt for remainder once finished) 
Service Provided (Y/N) Days/Hours of operation 
Curative care (minor ailments)   
Antenatal   
Maternity   
PMTCT   
Child health/immunisation   
Family planning   
TB diagnosis   
TB treatment   
Chronic disease care   
VCT   
Home based care   
Post sexual assault services   
Other   
Other   
 
2.2  Can you tell me when each of these services are available? (fill in second column) 
 
2.3  I’d now like to ask you to draw me an organogram of the facility, showing me the structure of 
services and the reporting lines (Show example of an organogram; draw on the next page)  
 
Probe: if there are services which do not report to her/him what are their reporting lines? (draw a second diagramme if 
necessary) 
 
2.4 Who do you report to? _____________________________________ 
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Facility Organogram 
 
 
 
 
 
 
 
 
2.5 Can you tell me what staff you have available in this clinic/OPD? 
 
 
Category Full-time Part-time Unfilled 
posts 
Left in last 
year 
Joined in last 
year 
Doctors      
Professional nurses      
Enroled nurses      
Enroled nursing assistants      
Health promoters      
Dietician      
Social worker      
Psychologist/ 
Counsellor 
     
Clerical staff      
Cleaning staff      
Other      
Other      
2.6 Do you have any unfilled posts in this clinic? (fill in number next to category in table)  
2.7 In the last year, since ____ (month) have any staff left? (ditto) 
2.8 In the last year, since ____ (month) have you recruited any new staff (ditto) 
 
2.9 Please describe to me how the nursing staff are allocated to activities, in other words, who does 
what,  in this clinic/OPD? 
 
Probe overlapping functions; rotations  
 
 
 
 
 
2.7 Are there volunteers, lay workers or other kinds of community workers linked to this 
OPD/Clinic? Yes/No 
 
2.8 If yes, could you list the types of volunteers used and the tasks that they perform? 
 
Categories of Volunteers Tasks Remuneration 
   
   
   
   
 
2.9 Are any of these workers remunerated? (fill in the table – amount or N) 
2.10 Do you know your current daily clinical nurse workload in this clinic/OPD, in other words, on 
average how many patients do your primary health care nurses see on a daily basis? 
   
   patients 
  100 
 
 
2.11 Do you know how many patients you currently see in total in this OPD/clinic, on a: 
 
Daily basis?    patients 
 
Weekly basis?     patients 
 
3 Drug supplies 
 
3.1 Who manages the drug supply in this facility? 
Pharmacist  
Pharmacy assistant  
Professional nurses  
Other (state)  
  
 
3.2 How would describe the drug supply in this facility? (prompt a choice by reading out options)  
Almost never or never run out of essential drugs  
Sometimes run out of essential items  
Regularly run out of essential items  
Almost always out of some essential items  
 
Comments on drug supply 
 
 
 
3.3 Ask if you can check availability of the list of drugs at the end of the questionnaire and who to go 
to for this  (e.g. person working in pharmacy) 
  
4 Laboratory Capacity 
4.1 Are any of the following tests available on site at your facility? 
Syphilis (rapid RPR) Y N 
Pregnancy test Y N 
Haemoglobin Y N 
HIV rapid test Y N 
 
4.2 Are you able to order the following tests (if yes, ask turnaround times)? 
HIV (ELISA) Y N Turn around time for results 
CD4 count Y N  
Viral load Y N  
PCR Y N  
Sputum AFBs Y N  
Full blood count Y N  
Liver enzymes Y N  
Electrolytes Y N  
 
Comments on laboratory service 
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5 Referral systems 
 
5.1 Where do you refer patients who need hospitalisation? (relevant for clinic only) 
 
Name of facility  
 
5.2 How are patients transported to hospital? (relevant to clinic only) 
By ambulance if acutely ill  
Hospital/clinic taxi service  
Patients have to arrange their own transport  
Other (state)  
 
5.3 Where do you refer patients who need TB care? (if not provided on site) 
 
Name of facility  
 
5.4 If refer TB cases, do you (read out each question): 
Know the name of the person in charge of the TB service where you refer patients? Y N 
Ever discuss the management of individual patients with staff in the TB service? Y N 
Send patients with referral letters to the TB service? Y N 
Receive information back from the TB service on your patients you referred? Y N 
Provide transport for patients to get to the TB service? Y N 
 
 
Comments on referral system 
 
 
 
 
5.5 Do you run any support groups from this OPD/clinic?    Yes/No 
If yes, Can you list these support groups for me (prompt for target group if not obvious)? 
Type of support group Target group 
  
  
  
 
5.6 Do you have any relationships with NGOs in this area?  Yes/No 
 If yes, Can you tell me about these and what your relationship is with them? 
Name of NGO Nature of relationship 
  
  
  
 
6 Information Systems 
 
6.1 I’d like to know now about the collection of statistics in this OPD/clinic. Can you describe to me 
how the system of collecting statistics in this clinic works? 
 
Write verbatim response 
 
 
6.2 Do you have any computers in this OPD/clinic?  Yes/No 
  
If yes, how many?      
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Which services do they cover?       
  
 
6.3 Do you know, more-or-less, the following statistics for your clinic/OPD? 
Number of suspected TB cases in the last month?  
% of patients on ARVs who have dropped out?  
% pregnant women tested for HIV?  
Number of HIV tests conducted?  
 
7 Supervision 
 
Apart from yourself, are there any other people who provide support and supervision to the OPD/clinic? 
Yes/No 
 
If yes, please tell me about these people 
Source of supervision Who they supervise 
  
  
  
 
8 Integration 
 
I’d now like to ask your opinion of HIV/AIDS services in this clinic:  
 
8.1 In your opinion what are the strengths of the HIV/AIDS-related services in this OPD/clinic? 
 
 
 
 
 
 
 
 
 
 
8.2 In your opinion what are the areas of the HIV/AIDS-related services that are weak or that 
require attention in this OPD/clinic? 
 
 
 
 
 
 
 
 
 
8.3 Which best describes the HIV/AIDS activities in this facility (read out and ask to choose one)? 
A series of vertical activities completely separate from each other  
A series of activities partially coordinated with each other  
A well integrated set of activities  
A well integrated set of activities that is also well integrated into the 
activities of the clinic/OPD as a whole 
 
9 General 
 
9.1 Is there anything else that you would like to say about the facility and health care services 
provided?  
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9.2 Do you have any questions you would like to ask me? 
 
 
 
 
THANK YOU, THE INTERVIEW IS OVER 
 
Ask for assistance in doing the inventory of drug supplies, consulting the routine data and indicate that you are going to be 
drawing a map of the area 
 
Map of the facility (including waiting areas) 
 
 
 
 
 
Check-list of drug supply (to be collected in dispensary) 
 
General drugs and supplies Anti Retrovirals 
Sharps disposal containers Y N Stavudine caps 30mg (Stavir/d4T) Y N 
Condoms  Y N Stavudine caps 40mg (Stavir/d4T) Y N 
Ciprofloxacin tablets Y N Stavudine solution1mg/ml (Stavir/d4T) Y N 
Flagyl (Metronidazole) 400mg Y N Lamivudine tabs 150mg (3TC) Y N 
Erythromycin 250mg tabs  Y N Lamivudine solution 10mg (3TC) Y N 
Doxycycline 100mg tabs Y N Efavirenz caps 200mg (Stocrin /EFV) Y N 
Latex gloves Y N Efavirenz caps 50mg (Stocrin /EFV) Y N 
Rapid HIV/AIDS testing kits Y N Efavirenz tabs 600mg (Stocrin /EFV) Y N 
Purple topped blood specimen 
containers  
Y N Didanosine tabs 200mg (Videx/ddI) Y N 
Nevirapine tablets 200mg  Y N Didanosine tabs 100mg (Videx/ddI) Y N 
Nevirapine suspension 50mg/5ml Y N Didanosine tabs 50mg (Videx/ddI) Y N 
Nystatin Y N Zidovudine tabs 300mg (Retrovir/AZT) Y N 
Analgesia (paracetamol) Y N Zidovudine syrup 50mg/5ml (Retrovir/AZT) Y N 
Cotrimoxazole (Bactrim) syrup Y N Lopinavir/Ritonavir caps 133/33mg (Kaletra) Y N 
Cotrimoxazole (Bactrim) tablets Y N Lopinavir/Ritonavir suspension 80/20mg/ml 
(Kaletra) 
Y N 
Acyclovir 800mg Y N Ritonavir suspension 80mg/ml (Norvir) Y N 
Amitryptaline Y N Ritonavir caps 100mg (Norvir)  Y N 
Hydrocortisone cream Y N Abacavir tabs 300mg  Y N 
Loperamide 2mg Y N Abacavir solution 20mg/ml Y N 
Sputum containers Y N 
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Routine data 
 
From the routine information system record the following data elements for the previous six months 
 
Indicate which 6-month period you have recorded data:     
 
Indicator Mnth 1 Mnth 2 Mnth 3 Mnth 4 Mnth 5 Mnth 6 
Total head count       
Nurse clinical workload       
Absenteeism rate professional 
nurses 
      
Number of HIV tests (excluding 
antenatal) 
      
Number of HIV tests in antenatal 
clinic 
      
Number of first antenatal visits       
Total number of TB sputum sent       
Number of CD4 counts requested       
Number of PCR requested       
Number of viral loads requested       
Number of liver tests requested       
Total seen for ART – adults        
Total registered on ART- adults       
Deaths on ART       
Transfer out on ART       
 
Interviewer Notes (after the site visit on the same day record critical incidents, observations and general impressions) 
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University of the Witwatersrand 
School of Public Health 
Faculty of Health Sciences 
Information Sheet – Comprehensive Care Management and Treatment (CCMT) Manager 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng Province 
 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have collaborated on a number of HIV/AIDS projects in recent years. The theme of the current 
research is adherence to Anti Retrovirals. Our interest is specifically in the facility factors (for example, 
presence of lay counsellors) that promote adherence in patients, which we refer to as “organisational 
capacity”. Another team of students will be doing research on the patient side of adherence. Once 
completed, the two of studies will be combined in one report for Gauteng Province in which we hope to 
make recommendations for the strengthening adherence in treatment sites. We would be most grateful if 
you could help in this research by providing information on these factors that relate to Anti Retroviral 
adherence in patients.  
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that 
were randomly selected for the project. As the person responsible for the ARV programme in this facility 
we would like to interview you. The purpose of the research is to obtain a detailed understanding of the 
CCMT programme within this facility. This will include aspects such as staffing and resources within the 
programme, and how you see the link between the ARV programme and the rest of the facility. 
 
What can I expect and what will be expected of me? 
One of us will interview you and take notes using a semi-structured questionnaire. We will also ask your 
assistance in gathering information from registers. The interview will take about one hour or so to 
complete. Your views will be combined with those of other staff interviewed and neither your name nor 
that of the facility will feature in the report.   
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the interview or any additional 
information obtained from registers and routine data will only be known to the researcher. This 
information will not reflect peoples names or patient numbers and will only show case numbers via a 
coding system. By participating you will help us understand the challenges facing managers in 
implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
All information that is obtained in this study will be kept confidential. Please note that to ensure that this is 
maintained, interview schedules will be coded and will only indicate the date of the interview and the 
facility code. Your participation will remain anonymous. Information pertaining to interview schedules will 
be kept in a separate file from the rest of the report, under lock and key in a safe place by the researcher. 
 
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo Tel: 082 490 11214 Email: nickynaidoo@gmail.com 
Rebecca Pursell Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
Our supervisor is Professor Helen Schneider and she is contactable on: 
Tel: 011-242 9905   Email: helen.schneider@nhls.ac.za 
Sincerely,  Nicolette Prea Naidoo   Rebecca Pursell 
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Consent Form for  CCMT Manager 
 Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate? 
Yes/No 
 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes 
 
Do you agree to be interviewed for the project  Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo    Rebecca Pursell 
Tel: 082 490 1214    Tel: 082 828 7387 
Email: nickynaidoo@gmail.com   Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
CCMT (ART) Provider Interview Schedule 
 
1 Interview Details         
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: _______________ 
1.4 Facility code _____________ 
1.5 Data capturing: Date: _______________   By ______________________ 
___________________________________________________________________________ 
 
2 Department Profile  
 
2.1 On which days and during which times does the ART unit provide services to the public? 
 
2.2 When did the service open for the first time? ________month______year 
2.3 When did you start providing ART?  ______month ______year 
2.4 Since starting the service, how many patients … 
have you started on ART? Number or don’t know 
are still on ART in this service?  
on ART are children (<14 years)  
started treatment during pregnancy?  
are on the waiting list to start ART (cd4<200)?  
are still in the wellness programme (cd4>200)?  
are still waiting to be assessed (no cd4 count done)?  
 
2.4 On average, how many patients does the unit see in one day? 
 
 
2.5 I’d now like to ask you to draw me an organogram of the unit, showing me the structure of 
services and the reporting lines (Show example of an organogram; draw on the bottom of the page)  
 
Probe: if there are services which do not report to her/him what are their reporting lines? (draw a second diagramme if 
necessary) 
 
Unit Organogram diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Hours of 
operation 
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3 Staffing 
3.1 Please tell me about the staffing for the ART service  
Category Full-time Part-time Unfilled 
posts 
Left in last 
year 
Joined in last 
year 
Doctors      
Professional nurses      
Enroled nurses      
Enroled nursing assistants      
Lay counsellors      
Volunteers      
Dietician      
Social worker      
Psychologist      
Clerical staff      
Cleaning staff      
Other      
Other      
Do you have any unfilled posts in this unit? (fill in number next to category in table)  
In the last year, since ____ (month) have any staff left the unit? (ditto) 
In the last year, since ____ (month) have you recruited any new staff to the unit? (ditto) 
 
3.2 In a typical day, what are your duties? 
Probe overlapping functions, rotations-
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
_________ 
3.3 What training have the staff received in this unit on HIV/ART? 
Category No trained Type of training 
Doctors   
Nurses   
Lay 
counsellors/volunteers 
  
Clerical   
Other   
Other   
 
4.  Information Systems 
I’d now like you to ask questions about the record keeping system in your unit (fill in the table) 
4.1 Can you show me an example of a patient record at this clinic? 
Are there any standard forms in this record? 
Who designed this record? 
 
4.6 Is patient information recorded anywhere else? If yes, where? 
4.6 Do you keep any special registers at the clinic? 
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 Description Specific to ART 
service 
Paper or electronic Local, provincial or 
national design 
Standardised 
patient records 
    
Registers and 
record books 
    
Reporting 
forms  
    
 
4.6 How do you track the follow-up of patients in this unit? (alternatively  how do you track defaulters 
from the service?)  
 
 
 
 
 
 
4.5 What information (statistics, reports) do you send to the clinic/OPD, district, province and 
national authorities? (get copies of forms) 
Form/report To Via Frequency 
    
    
    
 
4.6 How do you assess whether your service/unit is performing adequately or not? (fill in table and 
probe if necessary) 
Analyse own data locally If yes, indicate frequency 
Get verbal feedback district or 
province 
 
Get written reports from district or 
province 
 
Get verbal feedback from national  
Get written feedback from 
national 
 
 
5.  Treatment preparation, adherence and support 
5.1 I’d now like to ask you about how you manage treatment preparation and adherence 
 
Step/procedure Description 
Describe the steps (verbal or written) or procedures involved in preparing people for ART 
  
  
  
Describe how you ensure that patients remain on (adhere to) treatment? 
  
  
How do you monitor adherence in individual patients? 
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5.2 Does treatment preparation and support involve any of the following (if not already mentioned): 
Treatment preparation 
Individual counseling/briefing 
Y/N / DK 
Group education  
Nomination of treatment supporter/buddy  
Home visit  
Knowledge questionnaire  
Consent forms or patient contract  
Written information/pamphlets  
Treatment support 
Follow-up appointments 
 
Pill boxes  
Tick sheets  
Adherence assessment 
Self reported adherence (3 or 4 day recall)  
Pill count  
Viral load monitoring  
Return for follow-up  
 
6 Pathways of care and referral 
I am going to ask you now to take me through what happens to a person before they arrive at this service 
and the various referral services at this clinic. 
6.1 A person attending a clinic or the OPD is suspected of having HIV infection or requests an HIV 
test … 
Where do they receive VCT?  
 
Where do they go after that? (cd4 
counts etc.) 
 
 
If their cd4 count is >200  what 
happens to them? 
 
If they are pregnant where do they 
go? 
 
 
When are patients referred to this 
service? 
 
Where do most of your patients 
come from? (e.g. referred after 
admission, from general OPD, 
ANC, TB, VCT) 
 
 
 
6.2 Where do you refer your patients who need TB care? (if not provided on site) 
 
Name of facility  
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If refer TB cases, do you (read out each question): 
Know the name of the person in charge of the TB service where you refer patients? Y N 
Ever discuss the management of individual patients with staff in the TB service? Y N 
Send patients with referral letters to the TB service? Y N 
Receive information back from the TB service on your patients you referred? Y N 
Provide transport for patients to get to the TB service? Y N 
 
 
6.3 How would you describe your relationships with the following services:  
 Good Fair Poor 
VCT    
TB    
PMTCT/antenatal    
In-patient departments    
General outpatient    
 
6.4 Do you run any support groups from this unit?    Yes/No 
If yes, Can you list these support groups for me (prompt for target group if not obvious)? 
Type of support group Target group (youth, women etc.) 
  
  
  
 
6.5 Do you have any relationships with NGOs in this area?  Yes/No 
 If yes, Can you tell me about these and what your relationship is with them? 
Name of NGO Nature of relationship 
  
  
  
 
6.6 Where do you refer patients who need hospitalisation? (relevant for clinic only) 
Name of facility __________________________________ 
 
7 Support Systems 
 
7.1 Can you describe to me who provides support and supervision to this service (position of person)? 
 
 Inside facility Frequency Outside facility Frequency 
General supervision 
(e.g. promotion, 
absenteeism) 
    
Supervision of 
programme activities 
(ARV/CCMT)  
    
Clinical support 
 
 
    
 
8.  Supplies and infrastructure 
8.1 Who manages the drug supply for this service?  
Dedicated pharmacist for service  
By facility pharmacist  
Other (no pharmacist)  
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8.2 Where are the drugs stored? 
Separately from other facility drug supplies  
With other drug supplies  
  
 
8.3 Has the unit experienced stock out of ARV drugs in the past 6 months?  Yes/No 
 
If yes, how many times did this occur? ___________ 
 
8.4 Comments on drug supply 
 
 
 
 
 
9 Laboratory Capacity 
9.1 What laboratory tests are offered at the ART clinic?  
HIV (ELISA) Y N On or off-site Turn around time if off-site 
CD4 count Y N   
Viral load Y N   
PCR Y N   
Sputum AFBs Y N   
Full blood count Y N   
Liver enzymes Y N   
Electrolytes Y N   
 
10  Policy, Protocols and Standard Treatment Guidelines 
10.1 W hat written guidelines do you have available in the ART/CCMT service? 
(Take note of guidelines posted on the walls when doing the walkabout) 
 
Essential drug list and standard treatment guidelines for South African Primary 
Health Care  services  
Y N 
Feeding of infants of HIV positive mothers   
Prevention and treatment of opportunistic and HIV related diseases in adults   
Prevention of mother-to-child HIV transmission and management of HIV 
positive pregnant women 
  
Managing HIV in children   
VCT protocol/manual/booklet   
Tuberculosis (TB) and HIV/AIDS   
Protocol for management of a person with a STI (1998 or 1999 or more recent)    
HIV strategic plan for South Africa 2000-2005   
National guideline on home-based care and community based care   
Protocol/guidelines for PMTCT   
Management of occupational exposure to HIV (PEP guidelines)/Protocol for 
needle-stick injury 
  
The South African TB Control Programme Practical Guidelines 2000 (or more 
recent) 
  
Flow charts on TB diagnosis – New patients (blue) (either in TB control 
guidelines book or on a clinic/CHC wall, nurse should show it to you) 
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11 Integration  
I’d now like to ask your general opinion of HIV/AIDS services in this clinic: 
 
 
11.1 In your opinion what are the strengths of the HIV/AIDS-related services in this OPD/CHC? 
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________ 
11.2 In your opinion what are the areas of the HIV/AIDS-related services that are weak or that 
require attention in this OPD/CHC? 
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________ 
11.3 Which best describes the HIV/AIDS activities in this facility (read out and ask to choose one)? 
A series of vertical activities completely separate from each other  
A series of activities partially coordinated with each other  
A well integrated set of activities  
A well integrated set of activities that is also well integrated into the 
activities of the clinic/OPD as a whole 
 
 
 
12 General 
 
Is there anything else that you would like to add about the ART programme at your unit? 
 
Response/Comments: 
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________ 
 
Do you have any questions that you would like to ask me? 
___________________________________________________________________________________ 
 
THANK YOU, THE INTERVIEW IS OVER. 
 
Interviewer Notes (after the site visit on the same day record critical incidents, observations and general impressions) 
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Map of the facility (including waiting areas, and indicating functions of various rooms – counselling, treatment, record 
keeping etc.) 
Drugs kept in lockable space Y/N 
Records kept in locked 
space/cabinet 
 
Visual privacy of: 
• counselling 
• consulting rooms 
 
Auditory privacy of: 
• Counselling 
• Consulting rooms 
 
 
 
 
Routine data (if not already obtained) 
 
From the routine information system record the following data elements for the prior six months 
 
Indicate which 6-month period you have recorded data:     
 
Indicator Mnth 1 Mnth 2 Mnth 3 Mnth 4 Mnth 5 Mnth 6 
Number of CD4 counts requested       
Number of PCR requested       
Number of viral loads requested       
Number of liver tests requested       
Total seen for ART – adults        
Total registered on ART- adults       
Deaths on ART       
Transfer out on ART       
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University of Witwatersrand 
School of Public Health 
Faculty of Health Sciences 
 
Information Sheet – Manager of Tuberculosis Clinic / Unit 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng Province 
 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have collaborated on a number of HIV/AIDS projects in recent years. The theme of the current 
research is adherence to Anti Retroviral treatment. Our interest is specifically in the facility factors (for 
example, presence of lay counsellors) that promote adherence in patients, which we refer to as 
“organisational capacity”. Another team of students will be doing research on the patient side of 
adherence. Once completed, the two of studies will be combined in one report for Gauteng Province in 
which we hope to make recommendations for the strengthening adherence in treatment sites. We would be 
most grateful if you could help in this research by providing information on these factors that relate to Anti 
Retroviral adherence in patients. 
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that 
were randomly selected for the project. As the manger of the TB service, we would like to interview you. 
The purpose of the interview with you is to obtain a general understanding of the service you provide and 
how you see the link between the ART and TB programmes. 
 
What can I expect and what will be expected of me? 
One of us will interview you and take notes using a semi-structured questionnaire. We will also ask your 
assistance in gathering information on aspects such as staffing and facility statistics. The interview will take 
about one hour or so to complete. All the findings of the study will be anonymous. Your views will be 
combined with those of other Facility Managers and neither your name nor that of the facility will feature 
in the report.   
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the interview or any additional 
information obtained from registers will only be known to the researcher. This information will not reflect 
peoples names or patient numbers and will only show case numbers via a coding system. By participating 
you will help us understand the challenges facing managers and professional health care staff in 
implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
All information that is obtained in this study will be kept confidential. Please note that to ensure that this is 
maintained, interview schedules will be coded and will only indicate the date of the interview and the 
facility code. Your participation will remain anonymous. Information pertaining to interview schedules will 
be kept in a separate file from the rest of the report, under lock and key in a safe place by the researcher. 
 
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo Tel: 082 490 1214  Email: nickynaidoo@gmail.com 
Rebecca Pursell Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
 
Our supervisor is Professor Helen Schneider and she is contactable on: 
Tel: 011-242 9905   Email: helen.schneider@nhls.ac.za 
 
Sincerely,  Nicolette Prea Naidoo   Rebecca Pursell 
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Consent Form for Manager of Tuberculosis Unit / Clinic 
 Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate? 
Yes/No 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes 
 
Do you agree to be interviewed for the project  Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo   Rebecca Pursell 
Tel: 082 490 1214   Tel: 082 828 7387 
Email: nickynaidoo@gmail.com  Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
  
TB Manager Interview Schedule 
 
1. Interview details        
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: ________________  
1.4 Facility code: _____________ 
1.5 Data capturing:  Date:   By:  
________________________________________________________________________ 
2 Profile of service 
 
2.1 What TB services do you provide at this clinic? (Prompt and tick relevant one) 
Diagnosis of TB (sputum & x-ray)  
Initiation of treatment of TB  
Follow-up treatment  
Voluntary counselling and testing for HIV  
None  
 
2.2 If yes, what days and times do you provide TB care at this OPD/clinic? 
 
2.3 If does not provide full spectrum where do you refer patients for…  
 Name of place where refer On-site or off-site 
Diagnosis of TB (sputum & x-ray)?   
Initiation of treatment of TB?   
Follow-up treatment?   
Voluntary counselling and testing for HIV?   
 
3.  Staffing 
3.1 Have staff in this TB service received training in HIV?   Yes/No 
3.2 If yes, what training have the staff received with regards to HIV? 
 
Staff 
No. trained in HIV  Name of training course/content 
Doctors   
Professional Nurses   
Auxiliary Nurses   
Other   
 
(Prompt for the following if not mentioned: clinical management, counselling, health promotion)  
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Hours of 
operation 
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4. Integration 
4.1 Does this unit share staff with other services within the OPD/clinic? Yes/No 
If yes,  
Which service? Which staff? 
  
  
  
 
4.2 Do you share space with the other service centres/units located in this OPD/clinic?    Yes/No 
If yes,  
Which service? Which space? 
  
  
  
 
4.3   Is it routine procedure within your facility to refer all TB patients to the VCT service? 
Yes  
No  
 
4.4 Similarly, is it routine procedure to refer HIV+ patients to be screened for TB? 
Yes  
No  
 
4.5 Do formal methods of communication and feedback exist between TB clinics and ART units, if 
patients are taking TB treatment and ART simultaneously? 
Yes  
No  
  
4.6 If yes, can you describe the process of feedback and communication between the two service 
centres?  
 
 
 
 
 
 
 
4.7 Do you (read out each question): 
Know the name of the person in charge of the closest ART site? Y N 
Ever discuss the management of individual patients with staff in the ART service? Y N 
Send patients with referral letters to the ART service? Y N 
Receive information back from the ART service on your patients you referred? Y N 
Provide transport for patients to get to the ART service? Y N 
 
4.8 Do you guidelines or protocols for initiating HIV+ patients who are taking ART on tuberculosis 
treatment? 
  Yes  
No  
  
4.9 What other protocols or treatment guidelines are used in the management of TB in patients with 
HIV? 
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4.10 Have you observed any general patterns of adherence to tuberculosis treatment among patients who 
are taking ART? If so, please describe these.  
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________ 
 
5. Information Systems 
5.1 Do you know what percentage of TB patients at this clinic are: 
Tested for HIV?   
Test positive for HIV?  
Complete treatment for patients with only TB? (treatment completion 
rate)? 
 
Complete treatment in patients receiving ART simultaneously?  
Are cured? (cure rate)  
 
5.2 Are there routine follow-up systems that are able to identify patients who are defaulting or have 
not returned for their drugs? 
 
 
 
5.3 If yes, please describe further 
 
 
 
5.4 If such systems exist, who is responsible for follow-up? 
 
 
 
6. Views on HIV services 
 
I’d now like to ask your opinion of HIV/AIDS services in this clinic:  
 
6.1 In your opinion what are the strengths of the HIV/AIDS-related services in this OPD/clinic? 
 
 
 
 
 
 
 
 
 
 
6.2 In your opinion what are the areas of the HIV/AIDS-related services that are weak or that 
require attention in this OPD/clinic? 
 
 
 
Yes  
No  
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7. General 
 
7.1 Can you think of anything that you feel would improve the functioning of the TB service and its  
 interaction with the ART programme? 
 
 
 
 
7.2 Is there anything else that you would like to say about this facility and health care services 
provided?  
 
 
 
 
 
 
7.3 Do you have any questions you would like to ask me? 
 
 
 
 
THANK YOU, THE INTERVIEW IS OVER  
 
 
Interviewer Notes (after the site visit on the same day record critical incidents, observations and general impressions) 
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University of Witwatersrand 
School of Public Health 
Faculty of Health Sciences 
 
Information Sheet – Head of VCT Service 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng 
Province 
 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have cooperated on a number of HIV/AIDS projects in recent years. The theme of the current 
research is adherence to Anti Retrovirals. Our interest is specifically in the facility factors (for instance, 
presence of lay counsellors) that promote adherence in patients, which we refer to as “organisational 
capacity”. Another team of students will be doing research on the patient side of adherence. Once 
completed, the two studies will be combined in one report for Gauteng Province in which we hope to 
make recommendations for the strengthening adherence in treatment sites. We would be most grateful if 
you could help in this research by providing information on these factors that relate to Anti Retroviral 
adherence in patients. 
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that 
were randomly selected for the project. We would like to interview you about your role as a VCT Service 
Provider. The purpose of the interview with you is to obtain a general understanding of the VCT service in 
which the ARV site is located, such as the staff and resources in the VCT service, and how you see the link 
between the VCT programme and the rest of the facility.   
 
What can I expect and what will be expected of me? 
One of us will interview you and take notes using a semi-structured questionnaire. We may also ask your 
help to collect information about staffing and statistics on the uptake of the VCT service. The interview 
will take about one hour or so to complete. All findings will remain anonymous. Your views will be 
combined with those of other Facility Managers and neither your name nor that of the facility will feature 
in the report.   
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the interview or any additional 
information obtained from registers will only be known to the researcher. This information will not reflect 
peoples names or patient numbers and will only show case numbers via a coding system. By participating 
you will help us understand the challenges facing managers and professional health care staff in 
implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
All information that is obtained in this study will be kept confidential. Please note that to ensure that this is 
maintained, interview schedules will be coded and will only indicate the date of the interview and the 
facility code. Your participation will remain anonymous. Information pertaining to interview schedules will 
be kept in a separate file from the rest of the report, under lock and key in a safe place by the researcher. 
 
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo Tel: 082 490 1214  Email: nickynaidoo@gmail.com 
Rebecca Pursell Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
 
Our supervisor is Professor Helen Schneider and she is contactable on: 
Tel: 011-242 9905   Email: helen.schneider@nhls.ac.za 
 
Sincerely,  Nicolette Prea Naidoo   Rebecca Pursell 
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Consent Form for VCT Service Provider 
 Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate?
 Yes/No 
 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes 
 
Do you agree to be interviewed for the project  Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo   Rebecca Pursell 
Tel: 082 490 1214   Tel: 082 828 7387 
Email: nickynaidoo@gmail.com  Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
  
VCT Service Provider Interview Schedule 
 
1. Interview details        
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: ________________  
1.4 Facility code: _____________ 
1.5 Data capturing:  Date:   By:  
___________________________________________________________________________________ 
2.  Clinic profile and staffing 
2.1 What days and times do you provide VCT at this OPD/clinic? 
 
2.2 For how long has this facility been providing VCT to patients? ________ months/years 
 
2.3 More or less, how many patients attended the voluntary counselling and testing service in the last 
month? ______ 
 
3 Pathways of Care 
 
I am going to ask you now to take me through the steps of what happens when a person visits this service. 
 
A person is referred to or attends the VCT unit for an HIV test. What steps do you follow? 
 
Step 1  
 
Step 2  
 
Step 3  
 
If the test is positive for HIV what happens next? 
Step 1  
 
Step 2  
 
Step 3  
 
 
If not already indicated If a patient is found to be HIV+, what is the process by which they receive ongoing 
care?  
Continue receiving care at 
this facility 
  
Referred to surrounding 
hospital 
 Site of referral 
Referred to Community     
Health Centre 
 Site of referral 
 
4. Staffing 
4.1 Please tell me about the staffing for the VCT service  
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Hours of 
operation 
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Category Full-time Part-
time 
Left in 
last year 
Joined in 
last year 
Salary/Renumeration 
Doctors      
Professional nurses      
Enroled nurses      
Enroled nursing assistants      
Lay counsellors      
Volunteers      
Other      
Other      
In the last year, since ____ (month) have any staff left the unit? (ditto) 
In the last year, since ____ (month) have you recruited any new staff to the unit? (ditto) 
 
4.2 Is there an ongoing programme of training and skills upgrading for staff in this clinic? 
Yes  
No  
 
4.3  If yes, what training have the staff in this unit received? 
 
Staff 
 
No. trained 
 
Name of training course 
Doctors   
Professional Nurses   
Auxiliary Nurses   
Lay counsellors   
 
5. Integration 
5.1 Does this unit share staff with other services within the OPD/clinic? Yes/No 
If yes,  
Which service? Which staff? 
  
  
  
 
5.2 Do you share space with the other service centres/units located in this OPD/clinic?    Yes/No 
If yes,  
 
Which service? Which space? 
  
  
  
 
5.3 What are the most common ways in which people reach the VCT service (read and ask to rank): 
 
TB service  
Antenatal  
General curative service  
Other clinics   
Community-based health promotion and 
campaigns 
 
Self referred  
Other  
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5.4 Do you (read out each question): 
Know the name of the person in charge of the closest ART site? Y N 
Ever discuss the management of individual patients with staff in the ART service? Y N 
Send patients with referral letters to the ART service? Y N 
Receive information back from the ART service on your patients you referred? Y N 
Provide transport for patients to get to the ART service? Y N 
 
5.5 What procedures for formal communication and feedback are there between this unit and staff in 
the referral facility? 
Procedures Yes No 
Written records in patient file   
Duplicate test results distributed   
Case meetings between clinicians   
Telephonic Contact   
 
6.  Information Systems 
6.1 What information is collected at facility level within the VCT service? 
 
 
 
6.2 Is there any mechanism for tracking referred patients movement through the health system? 
Yes  
No  
  
If yes, please explain further 
 
 
     
 
7. Views on HIV/AIDS related services 
 
I’d now like to ask your opinion of HIV/AIDS services in this clinic:  
 
7.1 In your opinion what are the strengths of the HIV/AIDS-related services in this OPD/clinic? 
 
 
 
 
 
 
 
7.2 In your opinion what are the areas of the HIV/AIDS-related services that are weak or that 
require attention in this OPD/clinic? 
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8.  General 
 
8.1 Can you think of anything that you feel would improve the functioning of the VCT service and its 
interaction with the ART programme? 
 
 
 
 
 
 
8.2 Do you have any questions you would like to ask me? 
 
 
 
 
THANK YOU, THE INTERVIEW IS OVER. 
 
 
Interviewer Notes (after the site visit on the same day record critical incidents, observations and general impressions) 
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University of Witwatersrand     
School of Public Health 
Faculty of Health Sciences 
________________________________________________________________________ 
Information Sheet – Antenatal Care Provider 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng Province 
 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have cooperated on a number of HIV/AIDS projects in recent years. The theme of the current 
research is adherence to Anti Retrovirals. Our interest is specifically in the facility factors (for instance, 
presence of lay counsellors) that promote adherence in patients, which we refer to as “organisational 
capacity”. Another team of students will be doing research on the patient side of adherence. Once 
completed, the two studies will be combined in one report for Gauteng Province in which we hope to 
make recommendations for the strengthening adherence in treatment sites. We would be most grateful if 
you could help in this research by providing information on these factors that relate to Anti Retroviral 
adherence in patients.  
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that 
were randomly selected for the project. We would like to interview you as an antenatal care provider in this 
facility. Specifically we are interested in the prevention of mother to child transmission (PMTCT) of HIV 
aspects of your work and how this links with the HIV treatment programme in this facility.  
 
What can I expect and what will be expected of me? 
One of us will interview you and take notes using a semi-structured questionnaire. We will ask you 
questions about examinations and tests done on pregnant women and where you refer them if they need 
HIV care. All the findings of the study will be anonymous. Your views will be combined with those of 
people interviewed and neither your name nor that of the facility will feature in the report.   
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the interview or any additional 
information obtained from registers and routine data will only be known to the researcher. This 
information will not reflect peoples names or patient numbers and will only show case numbers via a 
coding system. By participating you will help us understand the challenges facing managers in 
implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
All information that is obtained in this study will be kept confidential. Please note that to ensure that this is 
maintained, interview schedules will be coded and will only indicate the date of the interview and the 
facility code. Your participation will remain anonymous. Information pertaining to interview schedules will 
be kept in a separate file from the rest of the report, under lock and key in a safe place by the researcher. 
 
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo  Tel: 082 490 1214  Email: nickynaidoo@gmail.com 
Rebecca Pursell  Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
 
Our supervisor is Professor Helen Schneider and she is contactable on: 
Tel: 011-242 9905   Email: helen.schneider@nhls.ac.za 
Sincerely , 
Nicolette Prea Naidoo   Rebecca Pursell 
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Consent Form for PMTCT/Antenatal Care Provider 
Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate?
 Yes/No 
 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes  
 
Do you agree to be interviewed for the project Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo   Rebecca Pursell 
Tel: 082 490 1214   Tel: 082 828 7387 
Email: nickynaidoo@gmail.com  Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 Antenatal Care Provider Interview Schedule 
 
Interview Details:         
1.1 Interview schedule No: _____________    
1.2 Interviewer: ________________ 
1.3 Date of interview: _______________ 
1.4 Facility code _____________ 
1.5 Data capturing: Date: _______________   By ______________________ 
___________________________________________________________________________ 
2. Department Profile 
 
2.1 What days and times do you provide antenatal care at this OPD/clinic? 
Days Mon Tue Wed Thu Fri Sat Sun 
Times        
 
2.2 Do you provide PMTCT (prevention of mother to child transmission of HIV as a part of 
antenatal care?   Yes/No 
 
2.3 Could you describe what your role is in the PMTCT service? 
 
3. Pathways of Care  
I am going to ask you now to take me through the steps of what happens when a pregnant woman visits 
this clinic. 
A woman presents at the clinic for a booking visit. She arrives at the clinic  - what happens then? (probe for 
physical routing through facility) 
Step 1  
 
Step 2  
 
Step 3  
 
Step 4  
 
  
 
 
Probe for the following activities if not mentioned 
HIV–related activity Yes/No/Comment 
VCT offered?  
Counsellors in ANC?  
HIV testing on site?  
Other tests?  
  
If she turns out to be HIV positive what happens to her next? 
Step 1  
 
Step 2  
 
Step 3  
 
Step 4  
 
  
 
 
Probe for specifics if not mentioned 
  130 
HIV-related activity Comments 
Follow-up counselling?  
Staging?   
Who does CD4 count?  
Referral to any other 
service? 
 
  
 
 
If the woman is HIV positive and you suspect TB what do you do? 
 
Step 1  
 
Step 2  
 
 
 
 
4.  Staffing 
4.1 Have staff in this antenatal service received training in HIV?   Yes/No 
4.2 If yes, what training have the staff received with regards to HIV? 
 
Staff 
No. trained in HIV  Name of training course 
Doctors   
Professional Nurses   
Auxiliary Nurses   
Other   
 
4.3 Does this unit share staff with other services within the OPD/clinic? Yes/No 
If yes,  
Which service? Which staff? 
  
  
  
 
4.4 Do you share space with the other service centres/units located in this OPD/clinic?    Yes/No 
If yes,  
Which service? Which space? 
  
  
  
 
 
5. Information Systems 
5.1 What information is collected to allow for follow up of mothers and their infants? 
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5.2 Do you know what percentage of pregnant women in this antenatal clinic are: 
Tested for HIV?   
Test positive for HIV?  
 
6. Integration 
 
I’d now like to ask your opinion of HIV/AIDS services in this clinic:  
 
6.1 In your opinion what are the strengths of the HIV/AIDS-related services in this OPD/clinic? 
 
 
 
 
 
 
 
 
 
 
6.2 In your opinion what are the areas of the HIV/AIDS-related services that are weak or that 
require attention in this OPD/clinic? 
 
 
 
 
 
 
 
 
 
 
6.3 Which best describes the HIV/AIDS activities in this facility (read out and ask to choose one)? 
A series of vertical activities completely separate from each other  
A series of activities partially coordinated with each other  
A well integrated set of activities  
A well integrated set of activities that is also well integrated into the 
activities of the clinic/OPD as a whole 
 
 
6.4 Is there anything else that you would like to add about the PMTCT/Antenatal programme at your 
unit? 
 
Response/Comments: 
___________________________________________________________________________________
___________________________________________________________________________________ 
 
6.5 Do you have any questions that you would like to ask me? 
___________________________________________________________________________________ 
 
THANK YOU, THE INTERVIEW IS OVER 
 
 
Interviewer Notes (after the site visit on the same day record critical incidents, observations and general impressions) 
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University of Witwatersrand     
School of Public Health 
Faculty of Health Sciences 
Organisational capacity affecting patient adherence to Anti Retrovirals in Gauteng Province 
Information sheet for health care workers in clinics and outpatient departments concerning the 
completion of a self-administered questionnaire 
Good Day, 
We are two Masters in Public Health (MPH) students at the University of the Witwatersrand. One of us 
(Rebecca) is a social worker by training and the other (Nicolette) previously studied anatomy. As part of 
our MPH course we are participating in a collaborative research project between the Centre for Health 
Policy (CHP) in the School of Public Health and the Gauteng Department of Health (GDOH). CHP and 
GDOH have cooperated on a number of HIV/AIDS projects in recent years. The theme of the current 
research is adherence to Anti Retrovirals. Our interest is specifically in the facility factors (for instance, 
presence of lay counsellors) that promote adherence in patients, which we refer to as “organisational 
capacity”. Another team of students will be doing research on the patient side of adherence. Once 
completed, the two studies will be combined in one report for Gauteng Province in which we hope to 
make recommendations for the strengthening adherence in treatment sites. We would be most grateful if 
you could help in this research by providing information on these factors that relate to Anti Retroviral 
adherence in patients.  
 
Why we would like to interview you 
Your facility is one of four ARV treatment sites (two CHCs and two hospitals) in Regions A and B that were 
randomly selected for the project.  As part of a general assessment of the facility we are approaching all medical 
and nursing staff with the request to complete an anonymous questionnaire. This questionnaire asks some 
personal information (e.g. your age, current job description) and enquires as to your recent experiences of work 
(e.g. number of patients seen). However, most of the questionnaire asks you to rate your agreement with job-
related items and feelings. The questions are drawn from tools designed for people working in human service 
professions and have been tested in other settings. Completion of the questionnaire should take you no more than 
15 minutes. When completed each questionnaire must be placed and sealed in the envelope provided. Envelopes 
are to be handed to the person nominated by the staff for collection of completed questionnaires. 
 
Are there benefits or risks to the participants? 
There are no physical risks to the participant. The knowledge obtained from the questionnaire will only be 
known to the researcher. This information will not reflect peoples names and will only show coding 
numbers. By participating you will help us understand the challenges facing managers as well as 
professional staff in implementing a major new programme.  
 
Can I withdraw from this study? 
You can at any point in time withdraw from the study. This is a voluntary study and there will be no 
negative consequences should you choose not to participate or to withdraw. 
 
Confidentiality 
When you fill in the questionnaire, a descriptor or code will be allocated to you instead of your name. In 
addition, being that the questionnaire is anonymous, you are not required to fill in your name. This means 
that no one will be able to link what you have answered back to you. There will be no adverse 
consequences should you choose not to fill it in. 
 
What we plan to do with the information 
The results of the survey will feed in to recommendations to creating better management and evaluation 
mechanisms of the ART programme. This will be accomplished by identifying gaps in service provision 
and management of the programme.  
Should you have any questions concerning this study, please contact us:  
Nicolette Naidoo Tel: 082 490 1214  Email: nickynaidoo@gmail.com 
Rebecca Pursell Tel: 082 828 7387   Email: mwrebecc@mweb.co.za 
Our supervisor is Professor Helen Schneider and she is contactable on: 
Tel: 011-242 9905   Email: helen.schneider@nhls.ac.za 
Sincerely,  Nicolette Prea Naidoo  Rebecca Pursell 
 Consent Form for Professional Staff 
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 Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
 
Do you understand the purpose of the study, and what will be required of you if you agree to participate?
 Yes/No 
 
Have all your questions been answered? Yes/No 
 
If no, what further questions do you wish to ask? 
 
Do you understand that you are not obliged to agree to participate in this study?  Yes/No 
 
Do you understand that your decision to participate or not participate will not affect your job security in 
any way? Yes/No 
 
If answers to all above are yes 
 
Do you agree to be interviewed for the project  Yes/No 
 
Signature of Respondent (If yes) ________________ 
 
 
Names and contact details of investigators: 
Nicolette Prea Naidoo    Rebecca Pursell 
Tel: 082 490 1214    Tel: 082 828 7387 
Email: nickynaidoo@gmail.com   Email: mwrebecc@mweb.co.za 
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Organisational capacity affecting patient adherence to ARVs in Gauteng Province 
Self-administered Questionnaire for Professional Staff Working in ARV Sites 
 
INSTRUCTIONS 
This questionnaire requires you to tick (√ or X) or fill a series of boxes/lines. Please do not write your 
name on this questionnaire. If you feel uncomfortable answering any individual questions, you can leave it 
blank. 
________________________________________________________________________________________ 
 
BACKGROUND INFORMATION           
Today’s date:  
 
Your age    _______      years        
    
Your sex: 
 
Your current position (choose the one that best describes your position) 
 
 
 
 
 
Unit in which you are working: 
TB   
PMTCT/Antenatal  
ART/HIV  
VCT  
General Curative  
Other, specify  
 
What year did you start working at this clinic or hospital? ____________  
 
 
WORK AND PERSONAL SITUATION 
 
In the last week, how many hours would you say you worked?  _________ hours   
  
On your most recent working day, how many patients did you see? _______ patients   
 
In the last month, have any of your colleagues been unexpectedly absent from work? 
 
In the last year, have you experienced a needle-stick injury at work?  
    
 
Do you feel vulnerable to HIV in your personal life? 
 
  
Nursing assistant  
Enrolled nurse  
Professional nurse  
Ward or unit manager  
Other, specify  
Yes No 
Yes No 
Yes No 
MALE          FEMALE 
                     /2006 
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In the last month, did your department/clinic run out of any of the following? 
 
 
 
 
 
 
Please indicate your degree of agreement with the following statements:  
 Strongly 
disagree 
Disagree Not 
Sure 
Agree Strongly 
Agree 
I am confident about my ability to do my job      
HIV positive patients make too much extra work for 
staff 
     
I am motivated to carry out my duties       
There are enough staff to do the work in this unit      
Overall, I am very satisfied with my job      
Hospital/clinic management communicates well with 
staff in this site/hospital 
     
I feel very little commitment to this hospital or clinic      
The amount of work I have to do is too demanding      
I can see myself working overseas in the future      
The major satisfaction in my life comes from my 
work  
     
I am proud to be working at this clinic/hospital       
I only do this job so that I get paid at the end of the 
month 
     
I prefer to work in the public sector than in the 
private sector  
     
These days I don’t feel motivated to work as hard as I 
could 
     
I am glad I work for this facility rather than other 
facilities in this province 
     
I feel I’m positively influencing other people’s lives 
through my work 
     
I feel emotionally drained at the end of every day       
I intend to leave this hospital      
There have been too many changes at this hospital 
/clinic in the past year  
     
In this facility conflict hampers our work       
If I had a personal problem which affected my work I 
would feel free to discuss it with my supervisor or 
manager  
     
 
 
Thank You for Your Time 
 
 
 
 
 
 
 
 
 Yes No 
Drugs   
Disposables e.g. gloves   
Soap/hand spray   
